000143707112/312024Q3FALSEP1Mxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureivr:segmentivr:security00014370712024-01-012024-09-300001437071us-gaap:CommonStockMember2024-01-012024-09-300001437071ivr:SeriesBCumulativeRedeemablePreferredStockMember2024-01-012024-09-300001437071ivr:SeriesCCumulativeRedeemablePreferredStockMember2024-01-012024-09-3000014370712024-10-3100014370712024-09-3000014370712023-12-310001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2023-12-310001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2024-09-300001437071us-gaap:SeriesBPreferredStockMember2024-09-300001437071us-gaap:SeriesBPreferredStockMember2023-12-310001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-09-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2023-12-310001437071us-gaap:SeriesCPreferredStockMember2024-09-300001437071us-gaap:SeriesCPreferredStockMember2023-12-3100014370712024-07-012024-09-3000014370712023-07-012023-09-3000014370712023-01-012023-09-300001437071us-gaap:CommonStockMember2023-12-310001437071us-gaap:AdditionalPaidInCapitalMember2023-12-310001437071us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001437071us-gaap:RetainedEarningsMember2023-12-310001437071us-gaap:RetainedEarningsMember2024-01-012024-03-3100014370712024-01-012024-03-310001437071us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001437071us-gaap:CommonStockMember2024-01-012024-03-310001437071us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2024-01-012024-03-310001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-01-012024-03-310001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2024-03-310001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-03-310001437071us-gaap:CommonStockMember2024-03-310001437071us-gaap:AdditionalPaidInCapitalMember2024-03-310001437071us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001437071us-gaap:RetainedEarningsMember2024-03-3100014370712024-03-310001437071us-gaap:RetainedEarningsMember2024-04-012024-06-3000014370712024-04-012024-06-300001437071us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300001437071us-gaap:CommonStockMember2024-04-012024-06-300001437071us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2024-04-012024-06-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-04-012024-06-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2024-06-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-06-300001437071us-gaap:CommonStockMember2024-06-300001437071us-gaap:AdditionalPaidInCapitalMember2024-06-300001437071us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001437071us-gaap:RetainedEarningsMember2024-06-3000014370712024-06-300001437071us-gaap:RetainedEarningsMember2024-07-012024-09-300001437071us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001437071us-gaap:CommonStockMember2024-07-012024-09-300001437071us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2024-07-012024-09-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-07-012024-09-300001437071us-gaap:CommonStockMember2024-09-300001437071us-gaap:AdditionalPaidInCapitalMember2024-09-300001437071us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001437071us-gaap:RetainedEarningsMember2024-09-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2022-12-310001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2022-12-310001437071us-gaap:CommonStockMember2022-12-310001437071us-gaap:AdditionalPaidInCapitalMember2022-12-310001437071us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001437071us-gaap:RetainedEarningsMember2022-12-3100014370712022-12-310001437071us-gaap:RetainedEarningsMember2023-01-012023-03-3100014370712023-01-012023-03-310001437071us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001437071us-gaap:CommonStockMember2023-01-012023-03-310001437071us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2023-03-310001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2023-03-310001437071us-gaap:CommonStockMember2023-03-310001437071us-gaap:AdditionalPaidInCapitalMember2023-03-310001437071us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001437071us-gaap:RetainedEarningsMember2023-03-3100014370712023-03-310001437071us-gaap:RetainedEarningsMember2023-04-012023-06-3000014370712023-04-012023-06-300001437071us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001437071us-gaap:CommonStockMember2023-04-012023-06-300001437071us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2023-04-012023-06-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2023-04-012023-06-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2023-06-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2023-06-300001437071us-gaap:CommonStockMember2023-06-300001437071us-gaap:AdditionalPaidInCapitalMember2023-06-300001437071us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001437071us-gaap:RetainedEarningsMember2023-06-3000014370712023-06-300001437071us-gaap:RetainedEarningsMember2023-07-012023-09-300001437071us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001437071us-gaap:CommonStockMember2023-07-012023-09-300001437071us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2023-07-012023-09-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2023-07-012023-09-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2023-09-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2023-09-300001437071us-gaap:CommonStockMember2023-09-300001437071us-gaap:AdditionalPaidInCapitalMember2023-09-300001437071us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001437071us-gaap:RetainedEarningsMember2023-09-3000014370712023-09-300001437071us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberivr:NonAgencyCommercialMortgageBackedSecuritiesMember2024-09-300001437071us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberivr:NonAgencyResidentialMortgageBackedSecuritiesMember2024-09-300001437071us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-09-300001437071ivr:ThirtyYearFixedRatePassThroughMember2024-09-300001437071ivr:AgencyCollateralizedMortgageObligationsMember2024-09-300001437071ivr:AgencyCommercialMortgageBackedSecuritiesMember2024-09-300001437071ivr:NonAgencyCommercialMortgageBackedSecuritiesMember2024-09-300001437071ivr:NonAgencyResidentialMortgageBackedSecuritiesMember2024-09-300001437071ivr:NonAgencyResidentialMortgageBackedSecuritiesMember2024-01-012024-09-300001437071ivr:ThirtyYearFixedRatePassThroughMember2023-12-310001437071ivr:AgencyCollateralizedMortgageObligationsMember2023-12-310001437071ivr:NonAgencyCommercialMortgageBackedSecuritiesMember2023-12-310001437071ivr:NonAgencyResidentialMortgageBackedSecuritiesMember2023-12-310001437071ivr:NonAgencyResidentialMortgageBackedSecuritiesMember2023-01-012023-12-3100014370712023-01-012023-12-310001437071ivr:AgencyCommercialMortgageBackedSecuritiesMember2023-12-310001437071us-gaap:MortgageBackedSecuritiesMember2024-09-300001437071us-gaap:MortgageBackedSecuritiesMember2023-12-310001437071ivr:InterestOnlySecuritiesMember2024-09-300001437071ivr:InterestOnlySecuritiesMember2023-12-310001437071ivr:AgencyInterestOnlyandCollateralizedMortgageObligationsMember2024-09-300001437071ivr:NonAgencyIOMember2024-09-300001437071ivr:AgencyInterestOnlyandCollateralizedMortgageObligationsMember2023-12-310001437071ivr:NonAgencyIOMember2023-12-310001437071ivr:AgencyResidentialMortgageBackedSecuritiesMember2024-07-012024-09-300001437071ivr:AgencyCommercialMortgageBackedSecuritiesMember2024-07-012024-09-300001437071ivr:NonAgencyCommercialMortgageBackedSecuritiesMember2024-07-012024-09-300001437071ivr:NonAgencyResidentialMortgageBackedSecuritiesMember2024-07-012024-09-300001437071us-gaap:MortgageBackedSecuritiesOtherMember2024-07-012024-09-300001437071ivr:AgencyResidentialMortgageBackedSecuritiesMember2023-07-012023-09-300001437071ivr:NonAgencyCommercialMortgageBackedSecuritiesMember2023-07-012023-09-300001437071ivr:NonAgencyResidentialMortgageBackedSecuritiesMember2023-07-012023-09-300001437071us-gaap:USTreasurySecuritiesMember2023-07-012023-09-300001437071us-gaap:MortgageBackedSecuritiesOtherMember2023-07-012023-09-300001437071ivr:AgencyResidentialMortgageBackedSecuritiesMember2024-01-012024-09-300001437071ivr:AgencyCommercialMortgageBackedSecuritiesMember2024-01-012024-09-300001437071ivr:NonAgencyCommercialMortgageBackedSecuritiesMember2024-01-012024-09-300001437071us-gaap:USTreasurySecuritiesMember2024-01-012024-09-300001437071us-gaap:MortgageBackedSecuritiesOtherMember2024-01-012024-09-300001437071ivr:AgencyResidentialMortgageBackedSecuritiesMember2023-01-012023-09-300001437071ivr:NonAgencyCommercialMortgageBackedSecuritiesMember2023-01-012023-09-300001437071ivr:NonAgencyResidentialMortgageBackedSecuritiesMember2023-01-012023-09-300001437071us-gaap:USTreasurySecuritiesMember2023-01-012023-09-300001437071us-gaap:MortgageBackedSecuritiesOtherMember2023-01-012023-09-300001437071srt:MinimumMember2024-01-012024-09-300001437071srt:MaximumMember2024-01-012024-09-300001437071ivr:AgencyResidentialMortgageBackedSecuritiesMember2024-09-300001437071ivr:AgencyResidentialMortgageBackedSecuritiesMember2023-12-310001437071ivr:AgencyResidentialMortgageBackedSecuritiesMember2023-01-012023-12-310001437071ivr:SecuredDebtExcludingAssetbackedSecuritiesMember2024-09-300001437071ivr:SecuredDebtExcludingAssetbackedSecuritiesMember2024-01-012024-09-300001437071ivr:SecuredDebtExcludingAssetbackedSecuritiesMember2023-12-310001437071ivr:SecuredDebtExcludingAssetbackedSecuritiesMember2023-01-012023-12-310001437071us-gaap:AssetPledgedAsCollateralMemberivr:AgencyResidentialMortgageBackedSecuritiesMember2024-09-300001437071us-gaap:AssetPledgedAsCollateralMemberivr:AgencyResidentialMortgageBackedSecuritiesMember2023-12-310001437071us-gaap:AssetPledgedAsCollateralMemberivr:AgencyCommercialMortgageBackedSecuritiesMember2024-09-300001437071us-gaap:AssetPledgedAsCollateralMemberivr:AgencyCommercialMortgageBackedSecuritiesMember2023-12-310001437071us-gaap:AssetPledgedAsCollateralMember2024-09-300001437071us-gaap:AssetPledgedAsCollateralMember2023-12-310001437071ivr:RestrictedCashMemberus-gaap:AssetPledgedAsCollateralMemberivr:InterestRateSwapsFuturesContractsAndCurrencyForwardContractsMember2024-09-300001437071ivr:RestrictedCashMemberus-gaap:AssetPledgedAsCollateralMemberivr:InterestRateSwapsFuturesContractsAndCurrencyForwardContractsMember2023-12-310001437071us-gaap:AssetPledgedAsCollateralMemberivr:InterestRateSwapsFuturesContractsAndCurrencyForwardContractsMember2024-09-300001437071us-gaap:AssetPledgedAsCollateralMemberivr:InterestRateSwapsFuturesContractsAndCurrencyForwardContractsMember2023-12-310001437071us-gaap:MortgageBackedSecuritiesMemberus-gaap:AssetPledgedAsCollateralMember2024-09-300001437071us-gaap:MortgageBackedSecuritiesMemberus-gaap:AssetPledgedAsCollateralMember2023-12-310001437071ivr:RestrictedCashMemberus-gaap:AssetPledgedAsCollateralMember2024-09-300001437071ivr:RestrictedCashMemberus-gaap:AssetPledgedAsCollateralMember2023-12-310001437071us-gaap:RepurchaseAgreementsMember2024-09-300001437071us-gaap:RepurchaseAgreementsMember2023-12-310001437071us-gaap:InterestRateSwapMember2023-12-310001437071us-gaap:InterestRateSwapMember2024-01-012024-09-300001437071us-gaap:InterestRateSwapMember2024-09-300001437071ivr:FuturesContractsMember2023-12-310001437071ivr:FuturesContractsMember2024-01-012024-09-300001437071ivr:FuturesContractsMember2024-09-300001437071ivr:TBAPurchaseContractsMember2023-12-310001437071ivr:TBAPurchaseContractsMember2024-01-012024-09-300001437071ivr:TBAPurchaseContractsMember2024-09-300001437071ivr:TBASaleContractsMember2023-12-310001437071ivr:TBASaleContractsMember2024-01-012024-09-300001437071ivr:TBASaleContractsMember2024-09-300001437071us-gaap:InterestRateSwapMember2023-07-012023-09-300001437071us-gaap:InterestRateSwapMember2023-01-012023-09-300001437071us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMemberus-gaap:InterestRateSwapMember2023-12-310001437071ivr:LessThanThreeYearsMemberivr:InterestRateSwapFixedRateMember2024-09-300001437071ivr:LessThanThreeYearsMemberivr:InterestRateSwapFixedRateMember2024-01-012024-09-300001437071ivr:ThreeToFiveYearsMemberivr:InterestRateSwapFixedRateMember2024-09-300001437071ivr:ThreeToFiveYearsMemberivr:InterestRateSwapFixedRateMember2024-01-012024-09-300001437071ivr:FiveToSevenYearsMemberivr:InterestRateSwapFixedRateMember2024-09-300001437071ivr:FiveToSevenYearsMemberivr:InterestRateSwapFixedRateMember2024-01-012024-09-300001437071ivr:SevenToTenYearsMemberivr:InterestRateSwapFixedRateMember2024-09-300001437071ivr:SevenToTenYearsMemberivr:InterestRateSwapFixedRateMember2024-01-012024-09-300001437071ivr:GreaterThan10YearsMemberivr:InterestRateSwapFixedRateMember2024-09-300001437071ivr:GreaterThan10YearsMemberivr:InterestRateSwapFixedRateMember2024-01-012024-09-300001437071ivr:InterestRateSwapFixedRateMember2024-09-300001437071ivr:InterestRateSwapFixedRateMember2024-01-012024-09-300001437071ivr:LessThanThreeYearsMemberivr:InterestRateSwapFixedRateMember2023-12-310001437071ivr:LessThanThreeYearsMemberivr:InterestRateSwapFixedRateMember2023-01-012023-12-310001437071ivr:ThreeToFiveYearsMemberivr:InterestRateSwapFixedRateMember2023-12-310001437071ivr:ThreeToFiveYearsMemberivr:InterestRateSwapFixedRateMember2023-01-012023-12-310001437071ivr:FiveToSevenYearsMemberivr:InterestRateSwapFixedRateMember2023-12-310001437071ivr:FiveToSevenYearsMemberivr:InterestRateSwapFixedRateMember2023-01-012023-12-310001437071ivr:GreaterThan10YearsMemberivr:InterestRateSwapFixedRateMember2023-12-310001437071ivr:GreaterThan10YearsMemberivr:InterestRateSwapFixedRateMember2023-01-012023-12-310001437071ivr:InterestRateSwapFixedRateMember2023-12-310001437071ivr:InterestRateSwapFixedRateMember2023-01-012023-12-310001437071us-gaap:InterestRateSwapMemberus-gaap:NondesignatedMember2024-07-012024-09-300001437071ivr:FuturesContractsMemberus-gaap:NondesignatedMember2024-07-012024-09-300001437071ivr:TBAsMemberus-gaap:NondesignatedMember2024-07-012024-09-300001437071us-gaap:NondesignatedMember2024-07-012024-09-300001437071us-gaap:InterestRateSwapMemberus-gaap:NondesignatedMember2023-07-012023-09-300001437071us-gaap:NondesignatedMember2023-07-012023-09-300001437071us-gaap:InterestRateSwapMemberus-gaap:NondesignatedMember2024-01-012024-09-300001437071ivr:FuturesContractsMemberus-gaap:NondesignatedMember2024-01-012024-09-300001437071ivr:TBAsMemberus-gaap:NondesignatedMember2024-01-012024-09-300001437071us-gaap:NondesignatedMember2024-01-012024-09-300001437071us-gaap:InterestRateSwapMemberus-gaap:NondesignatedMember2023-01-012023-09-300001437071us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2023-01-012023-09-300001437071ivr:TBAsMemberus-gaap:NondesignatedMember2023-01-012023-09-300001437071us-gaap:NondesignatedMember2023-01-012023-09-300001437071ivr:CentralClearingCounterpartyMember2024-09-300001437071us-gaap:FutureMember2024-09-300001437071ivr:CentralClearingCounterpartyMember2023-12-310001437071us-gaap:CashMember2023-12-310001437071us-gaap:CashMember2024-09-300001437071us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesMember2024-09-300001437071us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesMember2024-09-300001437071us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesMember2024-09-300001437071us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesMember2024-09-300001437071us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001437071us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001437071us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001437071us-gaap:FairValueMeasurementsRecurringMember2024-09-300001437071us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesMember2023-12-310001437071us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesMember2023-12-310001437071us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesMember2023-12-310001437071us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesMember2023-12-310001437071us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2023-12-310001437071us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2023-12-310001437071us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2023-12-310001437071us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2023-12-310001437071us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001437071us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001437071us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001437071us-gaap:FairValueMeasurementsRecurringMember2023-12-310001437071us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001437071us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-09-300001437071us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-09-300001437071us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310001437071us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001437071srt:AffiliatedEntityMemberivr:InvescoAdvisersInc.Member2024-07-012024-09-300001437071srt:AffiliatedEntityMemberivr:InvescoAdvisersInc.Member2024-01-012024-09-300001437071srt:AffiliatedEntityMemberivr:InvescoAdvisersInc.Member2023-07-012023-09-300001437071srt:AffiliatedEntityMemberivr:InvescoAdvisersInc.Member2023-01-012023-09-300001437071srt:ManagementMember2024-01-012024-09-300001437071srt:ManagementMemberivr:IncurredCostsPrepaidorExpensedMember2024-07-012024-09-300001437071srt:ManagementMemberivr:IncurredCostsPrepaidorExpensedMember2023-07-012023-09-300001437071srt:ManagementMemberivr:IncurredCostsPrepaidorExpensedMember2024-01-012024-09-300001437071srt:ManagementMemberivr:IncurredCostsPrepaidorExpensedMember2023-01-012023-09-300001437071srt:ManagementMemberivr:IncurredCostsChargedAgainstEquityasaCostofRaisingCapitalMember2024-07-012024-09-300001437071srt:ManagementMemberivr:IncurredCostsChargedAgainstEquityasaCostofRaisingCapitalMember2023-07-012023-09-300001437071srt:ManagementMemberivr:IncurredCostsChargedAgainstEquityasaCostofRaisingCapitalMember2024-01-012024-09-300001437071srt:ManagementMemberivr:IncurredCostsChargedAgainstEquityasaCostofRaisingCapitalMember2023-01-012023-09-300001437071srt:ManagementMember2024-07-012024-09-300001437071srt:ManagementMember2023-07-012023-09-300001437071srt:ManagementMember2023-01-012023-09-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2024-01-012024-09-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-01-012024-09-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2023-01-012023-09-300001437071us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2023-01-012023-09-300001437071us-gaap:SecuredOvernightFinancingRateSofrMemberus-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2024-09-300001437071ivr:LondonInterbankOfferedRateMemberus-gaap:PreferredStockMemberus-gaap:SeriesBPreferredStockMember2024-09-300001437071us-gaap:SecuredOvernightFinancingRateSofrMemberus-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-09-300001437071ivr:LondonInterbankOfferedRateMemberus-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-09-300001437071us-gaap:PreferredStockMemberus-gaap:PreferredStockMember2024-09-3000014370712024-08-3100014370712024-08-300001437071us-gaap:CommonStockMemberivr:EquityDistributionAgreementMember2024-09-300001437071us-gaap:CommonStockMemberivr:EquityDistributionAgreementMember2024-07-012024-09-300001437071us-gaap:CommonStockMemberivr:EquityDistributionAgreementMember2024-01-012024-09-300001437071us-gaap:CommonStockMemberivr:EquityDistributionAgreementMember2023-07-012023-09-300001437071us-gaap:CommonStockMemberivr:EquityDistributionAgreementMember2023-01-012023-09-300001437071us-gaap:CommonStockMember2024-09-300001437071us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-07-012024-09-300001437071ivr:AccumulatedEquityMethodInvestmentGainLossParentMember2024-07-012024-09-300001437071us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-07-012024-09-300001437071ivr:AccumulatedEquityMethodInvestmentGainLossParentMember2024-06-300001437071us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-06-300001437071us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-06-300001437071ivr:AccumulatedEquityMethodInvestmentGainLossParentMember2024-09-300001437071us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-09-300001437071us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-09-300001437071us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-07-012023-09-300001437071us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-07-012023-09-300001437071us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-07-012023-09-300001437071ivr:AccumulatedEquityMethodInvestmentGainLossParentMember2023-07-012023-09-300001437071ivr:AccumulatedEquityMethodInvestmentGainLossParentMember2023-06-300001437071us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-06-300001437071us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-06-300001437071ivr:AccumulatedEquityMethodInvestmentGainLossParentMember2023-09-300001437071us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-09-300001437071us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-09-300001437071us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-012024-09-300001437071us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-09-300001437071ivr:AccumulatedEquityMethodInvestmentGainLossParentMember2024-01-012024-09-300001437071us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-09-300001437071ivr:AccumulatedEquityMethodInvestmentGainLossParentMember2023-12-310001437071us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310001437071us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310001437071us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-09-300001437071us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-01-012023-09-300001437071us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-09-300001437071ivr:AccumulatedEquityMethodInvestmentGainLossParentMember2023-01-012023-09-300001437071ivr:AccumulatedEquityMethodInvestmentGainLossParentMember2022-12-310001437071us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310001437071us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001437071us-gaap:SeriesBPreferredStockMember2024-07-012024-09-300001437071us-gaap:SeriesBPreferredStockMember2024-04-012024-06-300001437071us-gaap:SeriesBPreferredStockMember2024-01-012024-03-310001437071us-gaap:SeriesBPreferredStockMember2023-07-012023-09-300001437071us-gaap:SeriesBPreferredStockMember2023-04-012023-06-300001437071us-gaap:SeriesBPreferredStockMember2023-01-012023-03-310001437071us-gaap:SeriesCPreferredStockMember2024-07-012024-09-300001437071us-gaap:SeriesCPreferredStockMember2024-04-012024-06-300001437071us-gaap:SeriesCPreferredStockMember2024-01-012024-03-310001437071us-gaap:SeriesCPreferredStockMember2023-07-012023-09-300001437071us-gaap:SeriesCPreferredStockMember2023-04-012023-06-300001437071us-gaap:SeriesCPreferredStockMember2023-01-012023-03-310001437071us-gaap:RestrictedStockUnitsRSUMember2024-07-012024-09-300001437071us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001437071us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001437071us-gaap:SeriesBPreferredStockMemberus-gaap:SubsequentEventMember2024-11-042024-11-040001437071us-gaap:SeriesCPreferredStockMemberus-gaap:SubsequentEventMember2024-11-042024-11-040001437071us-gaap:RedeemablePreferredStockMemberus-gaap:SubsequentEventMembersrt:ScenarioForecastMember2024-12-272024-12-270001437071us-gaap:SeriesBPreferredStockMemberus-gaap:SubsequentEventMembersrt:ScenarioForecastMember2024-12-272024-12-270001437071us-gaap:SeriesBPreferredStockMemberus-gaap:SubsequentEventMembersrt:ScenarioForecastMember2024-12-27

目录

美国

证券交易委员会

华盛顿特区20549 

_______________________________________________ 

FORm 10-Q 

_______________________________________________

(标记一个)
☒			根据1934年证券交易法第13或15(d)条款的季度报告。

截至2024年6月30日季度结束 2024年9月30日

或

☐			根据1934年证券交易法第13或15(d)条款的过渡报告

到                  天从发票日期计算，被视为商业合理。                 

委员会文件编号 001-34385

景顺抵押资本公司。

（根据其组织宪章规定的正式名称）

_______________________________________________

马里兰州。									26-2749336
（成立或组织的）州或其他辖区 或组织成立的州或其他司法管辖区)									(国税局雇主识别号码) 识别号码)
1331 Spring Street, N.W.,			Suite 2500,
亚特兰大，			佐治亚州						30309
（总部地址）									（邮政编码）

(404) 892-0896

（注册人的电话号码，包括区号） 

根据1934年证券交换法第12(b)条注册的证券：

每个班级的标题

交易符号

注册的每个交易所的名称

每股普通股，面值为0.01美元

IVR

纽约证券交易所

7.75%固定利率转浮动股份B系列累积可赎回优先股

IVR PrB

纽约证券交易所

7.50%固定至浮动C系列累积可赎回优先股

IVR PrC

纽约证券交易所

请用勾划标示出是否公司：（1）过去12个月内已提交证券交易法 1934 年第 13条或 15(d)条要求提交的所有报告（或对于公司需要提交该报告的较短期间），以及（2）过去90天公司一直受到该提交要求的影响。是  ☒不☐

请勾选以下选项，指示在上述12个月（或该注册者需要提交此类文件的较短期间）是否已经以电子方式提交了根据S-t法规（本章第232.405条）需要提交的互动式数据文件。是  ☒不☐

请勾选相应的选项，表明公司是否属于大型快速申报人、快速申报人、非快速申报人、小型报告公司或新兴成长型公司。请参见交易所法案第1202条中“大型快速申报人”、“快速申报人”、“小型报告公司”和“新兴成长型公司”的定义。

大型加速归档人

☐

加速归档人

☒

非加速申报者

☐

较小报告公司

☐

新兴成长型企业

☐

如果一家新兴成长型公司，请用勾选标记表示该申报人已选择不使用根据证交所法案13(a)条款提供的任何新的或修订过的财务会计准则的延长过渡期。 ☐

请以勾选表示，注册人是否为空壳公司（根据交易所法案第120亿2条定义）。 是☐不☒

截至2024年10月31日， 60,730,287 景顺抵押资本普通股的流通股份。

---

目录

景顺抵押资本股份有限公司。

目 录

 

						页面
第一部分 基本报表						1
项目1。			基本报表			1
			未经查核的简明合并资产负债表，截至 九月 2024年12月31日及2023年12月31日			1
			三个控制项未经审计的综合营运报表 9 2024年6月30日 九月 30、2024和2023年			2
			未经审计的综合损益简明综合报表（净损益）为三个控制项 9 2024年6月30日 九月 30、2024和2023年			3
			2024年3月31日结束的未经审核简明综合股东权益报表；2024年6月30日；2024年9月30日；2023年3月31日；2023年6月30日和2023年9月30日			4
			未经审核的缩编综合现金流量表为 9 2024年6月30日 九月 30、2024和2023年			6
			基本报表注记			7
项目2。			管理层对财务状况和业绩的讨论与分析			25
项目3。			市场风险的定量和定性披露。			49
项目4。			内部控制及程序			52
第二部分其他资讯						53
项目1。			法律诉讼			53
第1项事项			风险因素			53
项目2。			股票权益的未注册销售和资金用途			53
项目3。			优先证券违约			53
项目4。			矿业安全披露			53
项目5。			其他信息			53
第6项。			展品			53

---

目录

第I部分

项目1。 基本报表

景顺抵押资本及附属公司

简明综合资产负债表

(未经查核)

			截至日期
以千元为单位，除股份数量外的$			2024年9月30日						2023年12月31日
资产
按公平价值衡量的抵押担保证券（包括已质押证券$5,401,351 15.14,712,185分别为；考虑信用亏损备抵款项后净额为$542 15.1320及$，分别为：			5,873,696						5,045,306
美国财政部证券，按公允价值衡量			—						11,214
现金及现金等价物			48,254						76,967
限制性现金			120,199						121,670
与投资相关之应收帐款			26,739						26,604
按公允价值衡量的衍生品资产			12,035						939
其他资产			1,307						1,509
总资产			6,082,230						5,284,209
负债和股东权益
负债：
回购协议			5,184,885						4,458,695
分红派息应付款			24,292						19,384
应计利息应付			10,686						15,787
担保持有应付			336						2,475
应付帐款和应计费用			1,607						1,296
由于联属公司			3,421						3,907
负债总额			5,225,227						4,501,544
承诺与可能负债（详见附注14）：
股东权益：
普通股股本，面额$0.01 ； 50,000,000 授权股份数：
7.75% 固定至浮动 B 系列累积可赎优先股： 4,247,989 和 4,385,997 分别发行和流通中的股份（$106,200 15.1109,650 各自的总清算优先权）			102,678						106,014
7.50% 固定至浮动 C 系列累积可赎优先股： 7,277,523 和 7,545,439 分别发行和流通中的股份（$181,938 15.1188,636 两者分别为总清算优先权			175,995						182,474
普通股，面值$13,404,540，截至2024年6月30日已发行股票数为13,404,540股，截至2023年12月31日已发行股票数为13,312,568股0.01 ； 134,000,000 和 67,000,000 授权股份和已发行股份分别为 60,730,287 和 48,460,626 分别是已发行及尚未流通的股份			607						484
额外资本赠与金			4,119,347						4,011,138
其他综合收益累计额			361						698
保留盈利（超额分配）			(3,541,985)						(3,518,143)
股东权益总额			857,003						782,665
负债总额及股东权益合计			6,082,230						5,284,209

相关附注是这些基本报表的一个不可或缺的部分。

1

---

目录

景顺抵押资本及附属公司

综合营业损益汇缩陈述

(未经查核)

 

			截至9月30日的三个月												截至九月三十日止九个月
以千元为单位，除每股资料外			2024						2023						2024						2023
利息收入			73,825						75,132						210,436						215,847
利息费用			66,315						65,701						187,288						174,449
净利息收益			7,510						9,431						23,148						41,398
其他收入（损失）
投资收益（损失），净额			165,168						(224,897)						53,803						(272,620)
信贷损失备抵金额增加/减少			80						(43)						(222)						(212)
未纳入合并的企业之权益收益（损失）			—						2						(193)						4
衍生工具赚取（损失）净额			(127,345)						151,689						(5,922)						203,418
其它投资收入（损失），净额			—						—						—						(66)
其他财务收益（损失）			37,903						(73,249)						47,466						(69,476)
费用
管理费-关联方			2,888						3,090						8,694						9,237
总务与行政			1,805						1,691						5,544						5,743
总支出			4,693						4,781						14,238						14,980
净利润（损失）			40,720						(68,599)						56,376						(43,058)
优先股股东的股息			(5,474)						(5,772)						(16,567)						(17,474)
优先股回购和养老收益			25						347						426						711
归属于普通股股东之净利润（损失）			35,271						(74,024)						40,235						(59,821)
每股收益（损失）：
归属于普通股股东之净利润（损失）
基础			0.63						(1.62)						0.78						(1.40)
稀释			0.63						(1.62)						0.78						(1.40)

The accompanying notes are an integral part of these condensed consolidated financial statements.

2

---

Table of Contents

INVESCO MORTGAGE CAPITAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

 

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands			2024						2023						2024						2023
Net income (loss)			40,720						(68,599)						56,376						(43,058)
Other comprehensive income (loss):
Unrealized gain (loss) on mortgage-backed securities, net			(287)						(91)						(639)						(698)
Reclassification of unrealized loss on available-for-sale securities to (increase) decrease in provision for credit losses			—						43						302						212
Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to interest expense			—						(1,810)						—						(9,505)
Currency translation adjustments on investment in unconsolidated venture			—						—						—						(10)
Reclassification of currency translation loss on investment in unconsolidated venture to other investment income (loss), net			—						—						—						123
Total other comprehensive income (loss)			(287)						(1,858)						(337)						(9,878)
Comprehensive income (loss)			40,433						(70,457)						56,039						(52,936)
Dividends to preferred stockholders			(5,474)						(5,772)						(16,567)						(17,474)
Gain on repurchase and retirement of preferred stock			25						347						426						711
Comprehensive income (loss) attributable to common stockholders			34,984						(75,882)						39,898						(69,699)

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

---

Table of Contents

INVESCO MORTGAGE CAPITAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

For the three months ended March 31, 2024; June 30, 2024 and September 30, 2024

(Unaudited)

 

																																							Additional Paid in Capital						Accumulated Other Comprehensive Income (Loss)						Retained Earnings (Distributions in excess of earnings)						Total Stockholders’ Equity
			Series B Preferred Stock												Series C Preferred Stock
$ in thousands, except share amounts																											Common Stock
			Shares						Amount						Shares						Amount						Shares						Amount
Balance as of December 31, 2023			4,385,997						106,014						7,545,439						182,474						48,460,626						484						4,011,138						698						(3,518,143)						782,665
Net income (loss)			—						—						—						—						—						—						—						—						29,122						29,122
Other comprehensive income (loss)			—						—						—						—						—						—						—						(163)						—						(163)
Proceeds from issuance of common stock, net of offering costs			—						—						—						—						365,838						4						3,314						—						—						3,318
Stock awards			—						—						—						—						(870)						—						—						—						—						—
Repurchase and retirement of preferred stock			(93,347)						(2,256)						(95,917)						(2,320)						—						—						—						—						193						(4,383)
Common stock dividends			—						—						—						—						—						—						—						—						(19,530)						(19,530)
Preferred stock dividends			—						—						—						—						—						—						—						—						(5,585)						(5,585)
Amortization of equity-based compensation			—						—						—						—						—						—						128						—						—						128
Balance as of March 31, 2024			4,292,650						103,758						7,449,522						180,154						48,825,594						488						4,014,580						535						(3,513,943)						785,572
Net income (loss)			—						—						—						—						—						—						—						—						(13,466)						(13,466)
Other comprehensive income (loss)			—						—						—						—						—						—						—						113						—						113
Proceeds from issuance of common stock, net of offering costs			—						—						—						—						1,761,155						18						16,034						—						—						16,052
Stock awards			—						—						—						—						50,855						—						—						—						—						—
Repurchase and retirement of preferred stock			(44,661)						(1,080)						(105,492)						(2,551)						—						—						—						—						208						(3,423)
Common stock dividends			—						—						—						—						—						—						—						—						(20,255)						(20,255)
Preferred stock dividends			—						—						—						—						—						—						—						—						(5,508)						(5,508)
Amortization of equity-based compensation			—						—						—						—						—						—						131						—						—						131
Balance as of June 30, 2024			4,247,989						102,678						7,344,030						177,603						50,637,604						506						4,030,745						648						(3,552,964)						759,216
Net income (loss)			—						—						—						—						—						—						—						—						40,720						40,720
Other comprehensive income (loss)			—						—						—						—						—						—						—						(287)						—						(287)
Proceeds from issuance of common stock, net of offering costs			—						—						—						—						10,084,138						101						88,445						—						—						88,546
Stock awards			—						—						—						—						8,545						—						—						—						—						—
Repurchase and retirement of preferred stock			—						—						(66,507)						(1,608)						—						—						—						—						25						(1,583)
Common stock dividends			—						—						—						—						—						—						—						—						(24,292)						(24,292)
Preferred stock dividends			—						—						—						—						—						—						—						—						(5,474)						(5,474)
Amortization of equity-based compensation			—						—						—						—						—						—						157						—						—						157
Balance as of September 30, 2024			4,247,989						102,678						7,277,523						175,995						60,730,287						607						4,119,347						361						(3,541,985)						857,003

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

---

Table of Contents

INVESCO MORTGAGE CAPITAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

For the three months ended March 31, 2023; June 30, 2023 and September 30, 2023

(Unaudited)

																																							Additional Paid in Capital						Accumulated Other Comprehensive Income (Loss)						Retained Earnings (Distributions in excess of earnings)						Total Stockholders’ Equity
			Series B Preferred Stock												Series C Preferred Stock
$ in thousands, except share amounts																											Common Stock
			Shares						Amount						Shares						Amount						Shares						Amount
Balance as of December 31, 2022			4,537,634						109,679						7,816,470						189,028						38,710,916						387						3,901,562						10,761						(3,407,342)						804,075
Net income (loss)			—						—						—						—						—						—						—						—						21,463						21,463
Other comprehensive income (loss)			—						—						—						—						—						—						—						(4,857)						—						(4,857)
Proceeds from issuance of common stock, net of offering costs			—						—						—						—						2,930,069						29						35,763						—						—						35,792
Stock awards			—						—						—						—						6,259						—						—						—						—						—
Common stock dividends			—						—						—						—						—						—						—						—						(16,658)						(16,658)
Preferred stock dividends			—						—						—						—						—						—						—						—						(5,862)						(5,862)
Amortization of equity-based compensation			—						—						—						—						—						—						162						—						—						162
Balance as of March 31, 2023			4,537,634						109,679						7,816,470						189,028						41,647,244						416						3,937,487						5,904						(3,408,399)						834,115
Net income (loss)			—						—						—						—						—						—						—						—						4,078						4,078
Other comprehensive income (loss)			—						—						—						—						—						—						—						(3,163)						—						(3,163)
Proceeds from issuance of common stock, net of offering costs			—						—						—						—						2,888,639						29						30,939						—						—						30,968
Stock awards			—						—						—						—						43,980						—						—						—						—						—
Repurchase and retirement of preferred stock			(37,788)						(913)						(42,696)						(1,033)						—						—						—						—						364						(1,582)
Common stock dividends			—						—						—						—						—						—						—						—						(17,833)						(17,833)
Preferred stock dividends			—						—						—						—						—						—						—						—						(5,840)						(5,840)
Amortization of equity-based compensation			—						—						—						—						—						—						141						—						—						141
Balance as of June 30, 2023			4,499,846						108,766						7,773,774						187,995						44,579,863						445						3,968,567						2,741						(3,427,630)						840,884
Net income (loss)			—						—						—						—						—						—						—						—						(68,599)						(68,599)
Other comprehensive income (loss)			—						—						—						—						—						—						—						(1,858)						—						(1,858)
Proceeds from issuance of common stock, net of offering costs			—						—						—						—						3,880,763						39						42,305						—						—						42,344
Repurchase and retirement of preferred stock			(34,432)						(832)						(92,563)						(2,238)						—						—						—						—						347						(2,723)
Common stock dividends			—						—						—						—						—						—						—						—						(19,384)						(19,384)
Preferred stock dividends			—						—						—						—						—						—						—						—						(5,772)						(5,772)
Amortization of equity-based compensation			—						—						—						—						—						—						133						—						—						133
Balance as of September 30, 2023			4,465,414						107,934						7,681,211						185,757						48,460,626						484						4,011,005						883						(3,521,038)						785,025

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

---

Table of Contents

INVESCO MORTGAGE CAPITAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

			Nine Months Ended September 30,
$ in thousands			2024						2023
Cash Flows from Operating Activities
Net income (loss)			56,376						(43,058)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Amortization of premiums and (discounts), net			(9,943)						(4,412)
Realized and unrealized (gain) loss on derivative instruments, net			135,363						(13,391)
(Gain) loss on investments, net			(53,803)						272,620
Increase (decrease) in provision for credit losses			222						212
(Gain) loss from investments in unconsolidated ventures in excess of distributions received			193						(4)
Other amortization			417						(9,069)
Loss on foreign currency translation			—						123
Changes in operating assets and liabilities:
(Increase) decrease in operating assets			(2,091)						(3,106)
Increase (decrease) in operating liabilities			(5,429)						6,200
Net cash provided by (used in) operating activities			121,305						206,115
Cash Flows from Investing Activities
Purchase of mortgage-backed securities			(1,912,509)						(4,522,098)
Purchase of U.S. Treasury securities			—						(48,672)
Distributions from investments in unconsolidated ventures, net			307						41
Principal payments from mortgage-backed securities			261,933						260,942
Proceeds from sale of mortgage-backed securities			887,185						3,339,830
Proceeds from sale of U.S. Treasury securities			10,755						48,977
Settlement (termination) of swaps, TBAs, futures and forwards, net			(146,459)						19,611
Net change in due from counterparties and collateral held payable on derivative instruments			—						1,584
Net cash provided by (used in) investing activities			(898,788)						(899,785)
Cash Flows from Financing Activities
Proceeds from issuance of common stock			108,062						109,104
Repurchase of preferred stock			(9,389)						(4,305)
Proceeds from repurchase agreements			31,557,925						28,937,349
Principal repayments of repurchase agreements			(30,831,316)						(28,185,166)
Net change in due from counterparties and collateral held payable on repurchase agreements			(2,139)						(4,892)
Payments of deferred costs			(108)						(329)
Payments of dividends			(75,736)						(77,127)
Net cash provided by (used in) financing activities			747,299						774,634
Net change in cash, cash equivalents and restricted cash			(30,184)						80,964
Cash, cash equivalents and restricted cash, beginning of period			198,637						278,781
Cash, cash equivalents and restricted cash, end of period			168,453						359,745
Supplement Disclosure of Cash Flow Information
Interest paid			192,389						177,748
Non-cash Investing and Financing Activities Information
Net change in unrealized gain (loss) on mortgage-backed securities classified as available-for-sale			337						486
Dividends declared not paid			24,292						19,384
Net change in investment related receivable (payable)			(1,772)						80
Net change in foreign currency translation adjustment recorded in accumulated other comprehensive income			—						(113)

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

---

Table of Contents

INVESCO MORTGAGE CAPITAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 – Organization and Business Operations

Invesco Mortgage Capital Inc. (the “Company” or “we”) is a Maryland corporation primarily focused on investing in, financing and managing mortgage-backed securities ("MBS”) and other mortgage-related assets.

As of September 30, 2024, we were invested in:

•residential mortgage-backed securities (“RMBS”) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association (“Ginnie Mae”), or a federally chartered corporation such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”) (collectively “Agency RMBS”);

•commercial mortgage-backed securities (“CMBS”) that are guaranteed by a U.S. government agency such as Ginnie Mae or a federally chartered corporation such as Fannie Mae or Freddie Mac (collectively "Agency CMBS");

•CMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation (“non-Agency CMBS”); and

•RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation (“non-Agency RMBS”).

During the periods presented in these condensed consolidated financial statements, we also invested in U.S. Treasury securities and real estate-related financing arrangements in the form of unconsolidated ventures.

We conduct our business through IAS Operating Partnership L.P. (the “Operating Partnership”) and have one operating segment. We are externally managed and advised by Invesco Advisers, Inc. (our “Manager”), a registered investment adviser and an indirect, wholly-owned subsidiary of Invesco Ltd. (“Invesco”), a leading independent global investment management firm.

We elected to be taxed as a real estate investment trust (“REIT”) for U.S. federal income tax purposes under the provisions of the Internal Revenue Code of 1986. To maintain our REIT qualification, we are generally required to distribute at least 90% of our REIT taxable income to our stockholders annually. We operate our business in a manner that permits our exclusion from the “Investment Company” definition under the Investment Company Act of 1940, as amended (the “1940 Act”).

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation and Consolidation

Certain disclosures included in our Annual Report on Form 10-K are not required to be included on an interim basis in our quarterly reports on Form 10-Q. We have condensed or omitted these disclosures. Therefore, this Form 10-Q should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2023.

Our condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and consolidate the financial statements of the Company and its controlled subsidiaries. All significant intercompany transactions, balances, revenues and expenses are eliminated upon consolidation. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for a fair statement of our financial condition and results of operations for the periods presented.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Examples of estimates include, but are not limited to, estimates of the fair values of financial instruments, interest income on mortgage-backed securities and allowances for credit losses. Actual results may differ from those estimates.

7

---

Table of Contents

Significant Accounting Policies

There have been no changes to our accounting policies included in Note 2 to the consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2023 other than as detailed below.

Futures Contracts

We account for our futures contracts as derivative financial instruments. Futures contracts are recorded on our condensed consolidated balance sheets at fair value, and changes in fair value are recorded within gain (loss) on derivative instruments, net on our condensed consolidated statements of operations. Our futures contracts are exchange-traded and valued under the market approach using quoted prices for identical instruments in active markets.

Recently Issued Accounting Pronouncements

In November 2023, the Financial Standards Accounting Board issued an accounting standards update intended to improve reportable segment disclosure requirements on an annual and interim basis. The amendments require, among other items, enhanced disclosures around significant segment expenses regularly provided to the chief operating decision maker (“CODM”), as well as the CODM's title and position. Additionally, the amendments expand the scope of all segment reporting disclosure requirements to include those entities with only a single operating segment, such as us.

We are required to implement the amendments in our consolidated financial statements for the year ended December 31, 2024 and for interim periods thereafter.

Note 3 – Variable Interest Entities ("VIEs")

Our maximum risk of loss in VIEs in which we are not the primary beneficiary as of September 30, 2024 is presented in the table below.

$ in thousands			Carrying Amount						Company's Maximum Risk of Loss
Non-Agency CMBS			9,936						9,936
Non-Agency RMBS			7,673						7,673
Total			17,609						17,609

Refer to Note 4 - "Mortgage-Backed Securities" for additional details regarding these investments.

Note 4 – Mortgage-Backed Securities

The following tables summarize our MBS portfolio by asset type as of September 30, 2024 and December 31, 2023.

As of September 30, 2024
$ in thousands			Principal/ Notional Balance						Unamortized Premium (Discount)						Amortized Cost						Allowance for Credit Losses						Unrealized Gain/ (Loss), net						Fair Value						Period- end Weighted Average Yield (1)
Agency RMBS:
30 year fixed-rate pass-through			5,066,865						(105,046)						4,961,819						—						145,995						5,107,814						5.43		%
Agency-CMO (2)			539,741						(470,393)						69,348						—						3,851						73,199						9.91		%
Agency CMBS			664,661						(5,342)						659,319						—						15,755						675,074						4.64		%
Non-Agency CMBS			11,000						—						11,000						(542)						(522)						9,936						8.91		%
Non-Agency RMBS (3)(4)(5)			253,758						(246,927)						6,831						—						842						7,673						9.31		%
Total			6,536,025						(827,708)						5,708,317						(542)						165,921						5,873,696						5.41		%

(1)Period-end weighted average yield is based on amortized cost as of September 30, 2024 and incorporates future prepayment and loss assumptions when appropriate. Total represents period-end weighted average yield of all mortgage-backed securities.

(2)All Agency collateralized mortgage obligations (“Agency-CMO”) are interest-only securities (“Agency IO”).

(3)Non-Agency RMBS is 66.1% fixed rate, 33.2% variable rate, and 0.7% floating rate based on fair value. Coupon payments on variable rate investments are based upon changes in the underlying hybrid adjustable-rate mortgage (“ARM”) loan coupons, while coupon payments on floating rate investments are based upon a spread to a reference index.

(4)Of the total discount in non-Agency RMBS, $2.1 million is non-accretable calculated using the principal/notional balance and based on estimated future cash flows of the securities.

(5)Non-Agency RMBS includes interest-only securities ("non-Agency IO") which represent 96.7% of principal/notional balance, 34.4% of amortized cost and 30.9% of fair value.

8

---

Table of Contents

As of December 31, 2023
$ in thousands			Principal/Notional Balance						Unamortized Premium (Discount)						Amortized Cost						Allowance for Credit Losses						Unrealized Gain/ (Loss), net						Fair Value						Period- end Weighted Average Yield (1)
Agency RMBS:
30 year fixed-rate pass-through			5,005,512						(159,924)						4,845,588						—						106,886						4,952,474						5.33		%
Agency-CMO (2)			573,240						(498,355)						74,885						—						(127)						74,758						9.74		%
Non-Agency CMBS			11,000						(372)						10,628						(320)						(373)						9,935						9.58		%
Non-Agency RMBS (3)(4)(5)			275,061						(267,744)						7,317						—						822						8,139						9.10		%
Total			5,864,813						(926,395)						4,938,418						(320)						107,208						5,045,306						5.42		%

(1)Period-end weighted average yield is based on amortized cost as of December 31, 2023 and incorporates future prepayment and loss assumptions when appropriate. Total represents period-end weighted average yield of all mortgage-backed securities.

(2)All Agency-CMO are Agency IO.

(3)Non-Agency RMBS is 66.8% fixed rate, 32.5% variable rate and 0.7% floating rate based on fair value. Coupon payments on variable rate investments are based upon changes in the underlying hybrid ARM loan coupons, while coupon payments on floating rate investments are based upon a spread to a reference index.

(4)Of the total discount in non-Agency RMBS, $2.1 million is non-accretable calculated using the principal/notional balance and based on estimated future cash flows of the securities.

(5)Non-Agency RMBS includes non-Agency IO which represent 96.9% of principal/notional balance, 37.6% of amortized cost and 31.7% of fair value.

The following table presents the fair value of our available-for-sale securities and securities accounted for under the fair value option by asset type as of September 30, 2024 and December 31, 2023. We have elected the fair value option for our MBS purchased on or after September 1, 2016 and all of our RMBS interest-only securities. As of September 30, 2024 and December 31, 2023, approximately 99.7% of our MBS were accounted for under the fair value option.

			As of
			September 30, 2024																		December 31, 2023
$ in thousands			Available-for-sale Securities						Securities under Fair Value Option						Total Fair Value						Available-for-sale Securities						Securities under Fair Value Option						Total Fair Value
Agency RMBS:
30 year fixed-rate pass-through			—						5,107,814						5,107,814						—						4,952,474						4,952,474
Agency-CMO			—						73,199						73,199						—						74,758						74,758
Agency CMBS			—						675,074						675,074						—						—						—
Non-Agency CMBS			9,936						—						9,936						9,935						—						9,935
Non-Agency RMBS			5,439						2,234						7,673						5,743						2,396						8,139
Total			15,375						5,858,321						5,873,696						15,678						5,029,628						5,045,306

9

---

Table of Contents

The components of the carrying value of our MBS portfolio as of September 30, 2024 and December 31, 2023 are presented below. Accrued interest receivable on our MBS portfolio, which is recorded within investment related receivable on our condensed consolidated balance sheets, was $25.7 million as of September 30, 2024 (December 31, 2023: $22.3 million).

			As of
			September 30, 2024																		December 31, 2023
$ in thousands			MBS						Interest-Only Securities						Total						MBS						Interest-Only Securities						Total
Principal/notional balance			5,750,928						785,097						6,536,025						5,025,062						839,751						5,864,813
Unamortized premium			17,355						—						17,355						5,061						—						5,061
Unamortized discount			(131,667)						(713,396)						(845,063)						(169,342)						(762,114)						(931,456)
Allowance for credit losses			(542)						—						(542)						(320)						—						(320)
Gross unrealized gains (1)			163,888						6,501						170,389						107,899						3,523						111,422
Gross unrealized losses (1)			(1,835)						(2,633)						(4,468)						(393)						(3,821)						(4,214)
Fair value			5,798,127						75,569						5,873,696						4,967,967						77,339						5,045,306

(1)Gross unrealized gains and losses includes gains (losses) recognized in net income for securities accounted for under the fair value option as well as gains (losses) for available-for-sale securities which are recognized as adjustments to other comprehensive income. Realization occurs upon sale or settlement of such securities. Further detail on the components of our total gains (losses) on investments, net for the three and nine months ended September 30, 2024 and 2023 is provided below in this Note 4.

The following table summarizes our MBS portfolio according to estimated weighted average life classifications as of September 30, 2024 and December 31, 2023.

			As of
$ in thousands			September 30, 2024						December 31, 2023
Less than one year			—						—
Greater than one year and less than five years			1,970,485						189,845
Greater than or equal to five years			3,903,211						4,855,461
Total			5,873,696						5,045,306

The following tables present the estimated fair value and gross unrealized losses of our MBS by length of time that such securities have been in a continuous unrealized loss position as of September 30, 2024 and December 31, 2023.

As of September 30, 2024

			Less than 12 Months																		12 Months or More																		Total
$ in thousands			Fair Value						Unrealized Losses						Number of Securities						Fair Value						Unrealized Losses						Number of Securities						Fair Value						Unrealized Losses						Number of Securities
Agency RMBS:
30 year fixed-rate pass-through (1)			137,867						(570)						1						—						—						—						137,867						(570)						1
Agency-CMO (1)			5,030						(344)						1						14,312						(2,054)						4						19,342						(2,398)						5
Agency CMBS (1)			138,300						(732)						6						—						—						—						138,300						(732)						6
Non-Agency CMBS (2)			9,936						(522)						1						—						—						—						9,936						(522)						1
Non-Agency RMBS (3)			—						—						—						1,384						(246)						9						1,384						(246)						9
Total			291,133						(2,168)						9						15,696						(2,300)						13						306,829						(4,468)						22

(1)Fair value option has been elected for all Agency securities in an unrealized loss position.

(2)Unrealized losses on non-Agency CMBS are recorded in accumulated other comprehensive income. These losses are not reflected in an allowance for credit losses based on a comparison of discounted expected cash flows to current amortized cost basis.

(3)Includes non-Agency IO with a fair value of $1.1 million for which the fair value option has been elected. Such securities have unrealized losses of $235,000.

10

---

Table of Contents

As of December 31, 2023

			Less than 12 Months																		12 Months or More																		Total
$ in thousands			Fair Value						Unrealized Losses						Number of Securities						Fair Value						Unrealized Losses						Number of Securities						Fair Value						Unrealized Losses						Number of Securities
Agency RMBS:
Agency-CMO (1)			17,486						(849)						3						21,664						(2,574)						6						39,150						(3,423)						9
Non-Agency CMBS (2)			9,935						(373)						1						—						—						—						9,935						(373)						1
Non-Agency RMBS (3)			—						—						—						1,462						(418)						9						1,462						(418)						9
Total			27,421						(1,222)						4						23,126						(2,992)						15						50,547						(4,214)						19

(1)Fair value option has been elected for all Agency securities in an unrealized loss position.

(2)Unrealized losses on non-Agency CMBS are included in accumulated other comprehensive income. These losses are not reflected in an allowance for credit losses based on a comparison of discounted expected cash flows to current amortized cost basis.

(3)Includes non-Agency IO with a fair value of $1.2 million for which the fair value option has been elected. Such securities have unrealized losses of $399,000.

We recorded an $80,000 decrease in the provision for credit losses during the three months ended September 30, 2024 and a $222,000 increase in the provision during the nine months ended September 30, 2024 on a single non-Agency CMBS (three and nine months ended September 30, 2023: $43,000 and $212,000 increase in the provision, respectively). The following table presents a roll-forward of our allowance for credit losses.

						Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands						2024						2023						2024						2023
Beginning allowance for credit losses						(622)						(169)						(320)						—
Additions to the allowance for credit losses on securities for which credit losses were not previously recorded						—						—						—						(212)
Additional (increases) decreases to the allowance for credit losses on securities that had an allowance recorded in a previous period						80						(43)						(222)						—
Ending allowance for credit losses						(542)						(212)						(542)						(212)

The following table summarizes the components of our total gain (loss) on investments, net for the three and nine months ended September 30, 2024 and 2023.

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands			2024						2023						2024						2023
Gross realized gains on sale of MBS			4,963						—						5,111						5,363
Gross realized losses on sale of MBS			—						(33,157)						(9,898)						(62,769)
Net unrealized gains (losses) on MBS accounted for under the fair value option			160,205						(191,752)						59,048						(215,226)
Net unrealized gains (losses) on U.S. Treasury securities			—						—						(372)						—
Net realized gains (losses) on U.S. Treasury securities			—						12						(86)						12
Total gain (loss) on investments, net			165,168						(224,897)						53,803						(272,620)

11

---

Table of Contents

The following tables present components of interest income recognized for the three and nine months ended September 30, 2024 and 2023.

For the three months ended September 30, 2024

$ in thousands			Coupon Interest						Net (Premium Amortization)/Discount Accretion						Interest Income
Agency RMBS			66,337						1,298						67,635
Agency CMBS			5,286						168						5,454
Non-Agency CMBS			125						114						239
Non-Agency RMBS			264						(103)						161
Other (inclusive of interest earned on cash balances)			336						—						336
Total interest income			72,348						1,477						73,825

For the three months ended September 30, 2023

$ in thousands			Coupon Interest						Net (Premium Amortization)/Discount Accretion						Interest Income
Agency RMBS			70,754						2,465						73,219
Non-Agency CMBS			437						301						738
Non-Agency RMBS			285						(126)						159
U.S. Treasury Securities			—						292						292
Other (inclusive of interest earned on cash balances)			724						—						724
Total interest income			72,200						2,932						75,132

For the nine months ended September 30, 2024

$ in thousands			Coupon Interest						Net (Premium Amortization)/Discount Accretion						Interest Income
Agency RMBS			193,715						4,028						197,743
Agency CMBS			10,046						338						10,384
Non-Agency CMBS			376						372						748
Non-Agency RMBS			818						(338)						480
U.S. Treasury securities			22						(1)						21
Other (inclusive of interest earned on cash balances)			1,060						—						1,060
Total interest income			206,037						4,399						210,436

For the nine months ended September 30, 2023

$ in thousands			Coupon Interest						Net (Premium Amortization)/Discount Accretion						Interest Income
Agency RMBS			206,804						3,616						210,420
Non-Agency CMBS			1,404						888						2,292
Non-Agency RMBS			865						(384)						481
U.S. Treasury Securities			—						292						292
Other (inclusive of interest earned on cash balances)			2,362						—						2,362
Total interest income			211,435						4,412						215,847

12

---

Table of Contents

Note 5 - U.S. Treasury Securities

The following table presents the components of the carrying value of our U.S. Treasury security as of December 31, 2023. We sold the security during the first quarter of 2024. We did not hold any U.S. Treasury securities as of September 30, 2024.

									As of
$ in thousands									December 31, 2023
Principal balance									10,000
Unamortized premium									842
Amortized cost									10,842
Unrealized gain (loss), net									372
Fair value									11,214

Note 6 – Borrowings

We finance the majority of our investment portfolio through repurchase agreements. Our repurchase agreements bear interest at a contractually agreed upon rate and generally have maturities ranging from one to six months. We account for our repurchase agreements as secured borrowings since we maintain effective control of the financed assets. Our repurchase agreements are subject to certain financial covenants. We were in compliance with all of these covenants as of September 30, 2024.

The following tables summarize certain characteristics of our borrowings as of September 30, 2024 and December 31, 2023. Refer to Note 7 - "Collateral Positions" for collateral pledged and held under our repurchase agreements.

			As of
$ in thousands			September 30, 2024																		December 31, 2023
			Amount Outstanding						Weighted Average Interest Rate						Weighted Average Remaining Maturity (days)						Amount Outstanding						Weighted Average Interest Rate						Weighted Average Remaining Maturity (days)
Repurchase Agreements - Agency RMBS			4,535,956						5.15		%				33						4,458,695						5.53		%				20
Repurchase Agreements - Agency CMBS			648,929						5.16		%				25						—						N/A						N/A
Total Borrowings			5,184,885						5.15		%				32						4,458,695						5.53		%				20

13

---

Table of Contents

Note 7 - Collateral Positions

The following table summarizes the fair value of collateral that we pledged and held under our repurchase agreements, interest rate swaps and futures contracts as of September 30, 2024 and December 31, 2023. Refer to Note 2 - "Summary of Significant Accounting Policies - Fair Value Measurements" of our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023 and Note 2 of these condensed consolidated financial statements for a description of how we determine fair value. Agency RMBS and Agency CMBS collateral pledged is included in mortgage-backed securities on our condensed consolidated balance sheets. Cash collateral pledged on centrally cleared interest rate swaps and futures contracts is classified as restricted cash on our condensed consolidated balance sheets.

Cash collateral held that is not restricted for use is included in cash and cash equivalents on our condensed consolidated balance sheets and the liability to return the collateral is included in collateral held payable. Non-cash collateral held is only recognized if the counterparty defaults or if we sell the pledged collateral. As of September 30, 2024 and December 31, 2023, we did not recognize any non-cash collateral held on our condensed consolidated balance sheets.

$ in thousands			As of
Collateral Pledged			September 30, 2024						December 31, 2023
Repurchase Agreements:
Agency RMBS			4,726,277						4,712,185
Agency CMBS			675,074						—
Total repurchase agreements collateral pledged			5,401,351						4,712,185
Derivative Instruments:
Restricted cash			120,199						121,670
Total derivative instruments collateral pledged			120,199						121,670
Total Collateral Pledged:
Mortgage-backed securities			5,401,351						4,712,185
Restricted cash			120,199						121,670
Total Collateral Pledged			5,521,550						4,833,855
			As of
Collateral Held			September 30, 2024						December 31, 2023
Repurchase Agreements:
Cash			336						2,475
Non-cash collateral			1,481						39,130
Total repurchase agreements collateral held			1,817						41,605

Repurchase Agreements

Collateral pledged with our repurchase agreement counterparties is segregated in our books and records. The repurchase agreement counterparties have the right to resell and repledge the collateral posted but have the obligation to return the pledged collateral, or substantially the same collateral if agreed to by us, upon maturity of the repurchase agreement. Under the repurchase agreements, the respective lender retains the contractual right to mark the underlying collateral to fair value. We would be required to provide additional collateral to fund margin calls if the value of pledged assets declined. We intend to maintain a level of liquidity that will enable us to meet any reasonably anticipated margin calls.

The ratio of our total repurchase agreements collateral pledged to our total repurchase agreements outstanding was 104% as of September 30, 2024 (December 31, 2023: 106%) based on the fair value of the securities as reported in our condensed consolidated balance sheets.

Interest Rate Swaps

As of September 30, 2024 and December 31, 2023, all of our interest rate swaps were centrally cleared by a registered clearing organization such as the Chicago Mercantile Exchange (“CME”) and LCH Limited (“LCH”) through a Futures Commission Merchant (“FCM”). We are required to pledge initial margin and daily variation margin for our centrally cleared interest rate swaps that is based on the fair value of our contracts as determined by our FCM. Collateral pledged with our FCM is segregated in our books and records and can be in the form of cash or securities. Daily variation margin for centrally cleared

14

---

Table of Contents

interest rate swaps is characterized as settlement of the derivative itself rather than collateral and is recorded as gain (loss) on derivative instruments, net in our condensed consolidated statements of operations. Certain of our FCM agreements include cross default provisions.

Futures Contracts

We are required to pledge initial margin and daily variation margin for our futures contracts that is based on the fair value of our contracts as determined by our FCM. The daily variation margin payment for our futures contracts is characterized as settlement of the futures contract itself rather than collateral and is recorded as gain (loss) on derivative instruments, net in our condensed consolidated statement of operations.

Note 8 – Derivatives and Hedging Activities

The following table summarizes changes in the notional amount of our derivative instruments during 2024.

$ in thousands			Notional Amount as of December 31, 2023						Additions						Settlement, Termination, Expiration or Exercise						Notional Amount as of September 30, 2024
Interest Rate Swaps			4,065,000						2,640,000						(2,915,000)						3,790,000
Futures Contracts			—						750,000						(260,000)						490,000
TBA Purchase Contracts			—						1,100,000						(1,100,000)						—
TBA Sale Contracts			—						(1,100,000)						1,100,000						—
Total			4,065,000						3,390,000						(3,175,000)						4,280,000

Refer to Note 7 - "Collateral Positions" for further information regarding our collateral pledged to and received from our derivative counterparties.

Interest Rate Swaps

At each settlement date, we typically refinance each repurchase agreement at the market interest rate at that time. Our objectives in using interest rate derivatives are to add stability to interest expense and to manage our exposures to interest rate movements. To accomplish these objectives, we primarily use interest rate swaps as part of our interest rate risk management strategy. Under the terms of our interest rate swap contracts, we make fixed-rate payments to a counterparty in exchange for the receipt of floating-rate amounts over the life of the agreements without exchange of the underlying notional amount. To a lesser extent, we have also used interest rate swap contracts whereby we make floating-rate payments to a counterparty in exchange for the receipt of fixed-rate amounts as part of our overall risk management strategy.

In 2013, we discontinued cash flow hedge accounting for our interest rate swaps. Amounts recorded in accumulated other comprehensive income before we discontinued cash flow hedge accounting for our interest rate swaps were reclassified to interest expense on the condensed consolidated statements of operations as interest was accrued and paid on the related repurchase agreements over the remaining life of the interest rate swap agreements. We reclassified $1.8 million and $9.5 million as a decrease to interest expense during the three and nine months ended September 30, 2023, respectively. As of December 31, 2023, there were no gains or losses on discontinued cash flow hedges remaining in accumulated other comprehensive income.

15

---

Table of Contents

As of September 30, 2024 and December 31, 2023, we had interest rate swaps whereby we pay interest at a fixed rate and receive floating interest based on the secured overnight financing rate (“SOFR”) with the following maturities outstanding.

$ in thousands						As of September 30, 2024
Maturities						Notional Amount						Weighted Average Fixed Pay Rate						Weighted Average Floating Receive Rate						Weighted Average Years to Maturity
Less than 3 years						1,730,000						1.93		%				4.96		%				2.1
3 to 5 years						575,000						0.33		%				4.96		%				3.4
5 to 7 years						950,000						0.54		%				4.96		%				5.8
7 to 10 years						100,000						3.61		%				4.96		%				9.3
Greater than 10 years						435,000						1.84		%				4.96		%				19.0
Total						3,790,000						1.37		%				4.96		%				5.4

$ in thousands						As of December 31, 2023
Maturities						Notional Amount						Weighted Average Fixed Pay Rate						Weighted Average Floating Receive Rate						Weighted Average Years to Maturity
Less than 3 years						950,000						2.55		%				5.38		%				1.6
3 to 5 years						1,375,000						0.29		%				5.38		%				3.8
5 to 7 years						1,150,000						0.55		%				5.38		%				6.6
Greater than 10 years						590,000						1.75		%				5.38		%				21.4
Total						4,065,000						1.10		%				5.38		%				6.6

Futures Contracts

We use futures contracts to help mitigate the potential impact of changes in interest rates on our performance. As of September 30, 2024, our futures contracts represented short positions in Ultra 10 year U.S. Treasury Notes. We did not hold any futures contracts as of December 31, 2023.

To-Be-Announced Securities Forward Contracts (“TBAs”)

We primarily use TBAs that we do not intend to physically settle on the contractual settlement date as an alternative means of investing in and financing Agency RMBS. We did not have any TBAs outstanding as of September 30, 2024 or December 31, 2023.

Tabular Disclosure of the Effect of Derivative Instruments on the Balance Sheets

The table below presents the fair value of our derivative financial instruments, as well as their classification on the condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023.

$ in thousands

Derivative Assets

Derivative Liabilities

As of

As of

September 30, 2024

December 31, 2023

September 30, 2024

December 31, 2023

Balance Sheets

Fair Value

Fair Value

Balance Sheets

Fair Value

Fair Value

Interest Rate Swaps Asset

9,508

939

Interest Rate Swaps Liability

—

—

Futures Contracts

2,527

—

Futures Contracts

—

—

Total Derivative Assets

12,035

939

Total Derivative Liabilities

—

—

16

---

Table of Contents

The following tables summarize the effect of interest rate swaps, futures contracts, TBAs and currency forward contracts reported in gain (loss) on derivative instruments, net on the condensed consolidated statements of operations for the three and nine months ended September 30, 2024 and 2023.

$ in thousands						Three Months Ended September 30, 2024
Derivative not designated as hedging instrument						Realized gain (loss) on derivative instruments, net						Contractual net interest income (expense)						Unrealized gain (loss), net						Gain (loss) on derivative instruments, net
Interest Rate Swaps						(160,472)						40,883						517						(119,072)
Futures Contracts						(12,419)						—						2,527						(9,892)
TBAs						94						—						1,525						1,619
Total						(172,797)						40,883						4,569						(127,345)

$ in thousands						Three Months Ended September 30, 2023
Derivative not designated as hedging instrument						Realized gain (loss) on derivative instruments, net						Contractual net interest income (expense)						Unrealized gain (loss), net						Gain (loss) on derivative instruments, net
Interest Rate Swaps						84,565						72,126						(5,002)						151,689
Total						84,565						72,126						(5,002)						151,689

$ in thousands						Nine Months Ended September 30, 2024
Derivative not designated as hedging instrument						Realized gain (loss) on derivative instruments, net						Contractual net interest income (expense)						Unrealized gain (loss), net						Gain (loss) on derivative instruments, net
Interest Rate Swaps						(134,661)						129,441						8,569						3,349
Futures Contracts						(12,419)						—						2,527						(9,892)
TBAs						621						—						—						621
Total						(146,459)						129,441						11,096						(5,922)

$ in thousands						Nine Months Ended September 30, 2023
Derivative not designated as hedging instrument						Realized gain (loss) on derivative instruments, net						Contractual net interest income (expense)						Unrealized gain (loss), net						Gain (loss) on derivative instruments, net
Interest Rate Swaps						21,509						190,027						(7,658)						203,878
Currency Forward Contracts						(18)						—						—						(18)
TBAs						(1,880)						—						1,438						(442)
Total						19,611						190,027						(6,220)						203,418

Note 9 – Offsetting Assets and Liabilities

Certain of our repurchase agreements and derivative transactions are governed by underlying agreements that generally provide for a right of offset under master netting arrangements (or similar agreements) in the event of default or in the event of bankruptcy of either party to the transactions. Assets and liabilities subject to such arrangements are presented on a gross basis in the condensed consolidated balance sheets.

The following tables present information about the assets and liabilities that are subject to master netting arrangements (or similar agreements) and can potentially be offset on our condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023. The daily variation margin payments for centrally cleared interest rate swaps and futures contracts are characterized as settlement of the derivative itself rather than collateral. Our derivative assets of $9.5 million related to centrally cleared interest rate swaps and $2.5 million related to futures contracts as of September 30, 2024 (December 31, 2023: asset of $939,000 related to centrally cleared interest rate swaps) are not included in the table below as a result of this characterization of daily variation margin.

17

---

Table of Contents

As of September 30, 2024

																					Gross Amounts Not Offset with Financial Assets (Liabilities) in the Balance Sheets
$ in thousands			Gross Amounts of Recognized Assets (Liabilities)						Gross Amounts Offset in the Balance Sheets						Net Amounts of Assets (Liabilities) Presented in the Balance Sheets						Financial Instruments						Cash Collateral (Received) Pledged						Net Amount
Liabilities
Repurchase Agreements (1)			(5,184,885)						—						(5,184,885)						5,184,885						—						—
Total Liabilities			(5,184,885)						—						(5,184,885)						5,184,885						—						—

As of December 31, 2023

																					Gross Amounts Not Offset with Financial Assets (Liabilities) in the Balance Sheets
$ in thousands			Gross Amounts of Recognized Assets (Liabilities)						Gross Amounts Offset in the Balance Sheets						Net Amounts of Assets (Liabilities) Presented in the Balance Sheets						Financial Instruments						Cash Collateral (Received) Pledged						Net Amount
Liabilities
Repurchase Agreements (1)			(4,458,695)						—						(4,458,695)						4,458,695						—						—
Total Liabilities			(4,458,695)						—						(4,458,695)						4,458,695						—						—

(1)The fair value of securities pledged against our borrowings under repurchase agreements was $5.4 billion as of September 30, 2024 (December 31, 2023: $4.7 billion). We held $336,000 of cash collateral under repurchase agreements as of September 30, 2024 (December 31, 2023: $2.5 million). Gross amounts not offset are limited to the net amount of repurchase agreement liabilities presented sufficient to reduce the net amount to zero for each counterparty. Accordingly, cash collateral held under repurchase agreements is not shown in the table above, but the obligation to return the cash collateral is separately reported within collateral held payable on the condensed consolidated balance sheets.

Cash collateral pledged by us on our derivatives was $120.2 million as of September 30, 2024 (December 31, 2023: $121.7 million) of which $120.2 million relates to initial margin pledged on centrally cleared interest rate swaps and futures contracts (December 31, 2023: $121.7 million for centrally cleared interest rate swaps). Centrally cleared interest rate swaps and futures contracts are excluded from the tables above. We held no cash collateral on our derivatives as of September 30, 2024 or December 31, 2023.

18

---

Table of Contents

Note 10 – Fair Value of Financial Instruments

A three-level valuation hierarchy exists for disclosure of fair value measurements based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. The three levels are defined as follows:

•Level 1 Inputs – Quoted prices for identical instruments in active markets.

•Level 2 Inputs – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

•Level 3 Inputs – Instruments with primarily unobservable value drivers.

The following tables present our assets and liabilities measured at fair value on a recurring basis.

			As of September 30, 2024
			Fair Value Measurements Using:
$ in thousands			Level 1						Level 2						Level 3												Total at Fair Value
Assets:
Mortgage-backed securities (1)			—						5,873,696						—												5,873,696
Derivative assets			2,527						9,508						—												12,035
Total assets			2,527						5,883,204						—												5,885,731

			As of December 31, 2023
			Fair Value Measurements Using:
$ in thousands			Level 1						Level 2						Level 3						NAV as a practical expedient (3)						Total at Fair Value
Assets:
Mortgage-backed securities (1)			—						5,045,306						—						—						5,045,306
U.S. Treasury securities (2)			—						11,214						—						—						11,214
Derivative assets			—						939						—						—						939
Other assets			—						—						—						500						500
Total assets			—						5,057,459						—						500						5,057,959

(1)For more detail about the fair value of our MBS, refer to Note 4 - “Mortgage-Backed Securities”.

(2)For more information on U.S. Treasury securities, refer to Note 5 - “U.S. Treasury Securities”.

(3)Our investment in an unconsolidated venture was valued using the net asset value (“NAV”) as a practical expedient and was not subject to redemption, although investors could sell or transfer their interest at the approval of the general partner of the underlying funds. The unconsolidated venture made its final distribution in the first quarter of 2024.

The following table presents the carrying value and estimated fair value of our financial instruments that are not carried at fair value on the condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023.

			As of
			September 30, 2024												December 31, 2023
$ in thousands			Carrying Value						Estimated Fair Value						Carrying Value						Estimated Fair Value
Financial Liabilities
Repurchase agreements			5,184,885						5,185,346						4,458,695						4,458,662
Total			5,184,885						5,185,346						4,458,695						4,458,662

The estimated fair value of repurchase agreements is a Level 3 fair value measurement based on an expected present value technique. This method discounts future estimated cash flows using rates we determined best reflect current market interest rates that would be offered for repurchase agreements with similar characteristics and credit quality.

19

---

Table of Contents

Note 11 – Related Party Transactions

Our Manager is at all times subject to the supervision and oversight of our board of directors and has only such functions and authority as we delegate to it. Under the terms of our management agreement, our Manager and its affiliates provide us with our management team, including our officers and appropriate support personnel. Each of our officers is an employee of our Manager or one of its affiliates. We do not have any employees. Our Manager is not obligated to dedicate any of its employees exclusively to us, nor is our Manager obligated to dedicate any specific portion of time to our business. The costs of support personnel provided by our Manager for the three and nine months ended September 30, 2024 reimbursed or reimbursable by us were $494,000 and $1.1 million, respectively (September 30, 2023: $397,000 and $1.3 million, respectively).

Management Fee

We pay our Manager a fee equal to 1.50% of our stockholders' equity per annum. For purposes of calculating the management fee, stockholders' equity is calculated as average month-end stockholders' equity for the prior calendar quarter as determined in accordance with U.S. GAAP. Stockholders' equity may exclude one-time events due to changes in U.S. GAAP and certain non-cash items upon approval by a majority of our independent directors.

During the periods presented in these condensed consolidated financial statements, we did not pay any management fees on our investments in unconsolidated ventures that are managed by an affiliate of our Manager.

Expense Reimbursement

We are required to reimburse our Manager for operating expenses incurred on our behalf, including directors and officers insurance, accounting services, auditing and tax services, legal services, filing fees, and miscellaneous general and administrative costs. Our reimbursement obligation is not subject to any dollar limitation.

The following table summarizes the costs incurred on our behalf by our Manager during the three and nine months ended September 30, 2024 and 2023.

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands			2024						2023						2024						2023
Incurred costs, prepaid or expensed			2,420						2,442						5,308						5,130
Incurred costs, charged or expected to be charged against equity as a cost of raising capital			108						—						108						257
Total incurred costs, originally paid by our Manager			2,528						2,442						5,416						5,387

Note 12 – Stockholders’ Equity

Preferred Stock

In May 2022, our board of directors approved a share repurchase program for our Series B and Series C Preferred Stock. During the three and nine months ended September 30, 2024, we repurchased and retired no shares and 138,008 shares of Series B Preferred Stock, respectively, and 66,507 and 267,916 shares of Series C Preferred Stock, respectively. During the three and nine months ended September 30, 2023, we repurchased and retired 34,432 and 72,220 shares of Series B Preferred Stock, respectively, and 92,563 and 135,259 shares of Series C Preferred Stock, respectively. As of September 30, 2024, we had authority to repurchase 1,047,989 additional shares of our Series B Preferred Stock and 777,523 additional shares of our Series C Preferred Stock under the current preferred stock share repurchase program.

Holders of our Series B Preferred Stock are entitled to receive dividends at an annual rate of 7.75% of the liquidation preference of $25.00 per share or $1.9375 per share per annum until December 27, 2024. After December 27, 2024, holders are entitled to receive dividends at a floating rate equal to three-month CME Term SOFR and the applicable credit spread adjustment (0.26161%) plus a spread of 5.18% of the $25.00 liquidation preference per annum. Dividends are cumulative and payable quarterly in arrears.

Holders of our Series C Preferred Stock are entitled to receive dividends at an annual rate of 7.50% of the liquidation preference of $25.00 per share or $1.875 per share per annum until September 27, 2027. After September 27, 2027, holders are entitled to receive dividends at a floating rate equal to three-month CME Term SOFR and the applicable credit spread adjustment (0.26161%) plus a spread of 5.289% of the $25.00 liquidation preference per annum. Dividends are cumulative and payable quarterly in arrears.

We have the option to redeem shares of our Series B Preferred Stock on or after December 27, 2024 and shares of our Series C Preferred Stock on or after September 27, 2027 for $25.00 per share, plus any accumulated and unpaid dividends through the date of the redemption. Shares of Series B and Series C Preferred Stock are not redeemable, convertible into or

20

---

Table of Contents

exchangeable for any other property or any other securities of the Company before those times, except under circumstances intended to preserve our qualification as a REIT or upon the occurrence of a change in control.

On November 5, 2024, we announced our intention to redeem all outstanding shares of our Series B Preferred Stock on December 27, 2024. Refer to Note 15 - “Subsequent Events” for additional information.

Common Stock

In August 2024, the Company filed an Articles of Amendment to increase the number of shares of common stock, par value $0.01 per share, that the Company has authority to issue. Effective upon filing, the Articles of Amendment amended the Charter of the Company to increase the total authorized number of shares of common stock of the Company from 67,000,000 to 134,000,000.

As of September 30, 2024, we had 12,089,398 shares of our common stock remaining available for sale from time to time in at-the-market or privately negotiated transactions under our equity distribution agreement with placement agents. These shares are registered with the SEC under our shelf registration statement (as amended and/or supplemented).

During the three months ended September 30, 2024, we sold 10,084,138 shares of common stock under our equity distribution agreements for proceeds of $88.5 million, net of approximately $1.3 million in commissions and fees. During the nine months ended September 30, 2024, we sold 12,211,131 shares of common stock under our equity distribution agreements for proceeds of $107.9 million, net of approximately $1.5 million in commissions and fees. During the three months ended September 30, 2023, we sold 3,880,763 shares of common stock under an equity distribution agreement for proceeds of $42.3 million, net of approximately $575,000 in commissions and fees. During the nine months ended September 30, 2023, we sold 9,699,471 shares of common stock under an equity distribution agreement for proceeds of $109.1 million, net of approximately $1.5 million in commissions and fees.

During the three and nine months ended September 30, 2024 and 2023, we did not repurchase any shares of our common stock. As of September 30, 2024, we had authority to repurchase 1,816,359 shares of our common stock through our common stock share repurchase program.

Accumulated Other Comprehensive Income

The following tables present the components of total other comprehensive income (loss), net and accumulated other comprehensive income (“AOCI”) for the three and nine months ended September 30, 2024 and 2023. The tables exclude gains and losses on MBS that are accounted for under the fair value option.

			Three Months Ended September 30, 2024
$ in thousands			Equity method investments						Available-for-sale securities						Derivatives and hedging						Total
Total other comprehensive income (loss)
Unrealized gain (loss) on mortgage-backed securities, net			—						(287)						—						(287)
Total other comprehensive income (loss)			—						(287)						—						(287)
AOCI balance at beginning of period			—						648						—						648
Total other comprehensive income (loss)			—						(287)						—						(287)
AOCI balance at end of period			—						361						—						361

21

---

Table of Contents

			Three Months Ended September 30, 2023
$ in thousands			Equity method investments						Available-for-sale securities						Derivatives and hedging						Total
Total other comprehensive income (loss)
Unrealized gain (loss) on mortgage-backed securities, net			—						(91)						—						(91)
Reclassification of unrealized loss on available-for-sale securities to (increase) decrease in provision for credit losses			—						43						—						43
Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to interest expense			—						—						(1,810)						(1,810)
Total other comprehensive income (loss)			—						(48)						(1,810)						(1,858)
AOCI balance at beginning of period			—						31						2,710						2,741
Total other comprehensive income (loss)			—						(48)						(1,810)						(1,858)
AOCI balance at end of period			—						(17)						900						883

			Nine Months Ended September 30, 2024
$ in thousands			Equity method investments						Available-for-sale securities						Derivatives and hedging						Total
Total other comprehensive income (loss)
Unrealized gain (loss) on mortgage-backed securities, net			—						(639)						—						(639)
Reclassification of unrealized loss on available-for-sale securities to (increase) decrease in provision for credit losses			—						302						—						302
Total other comprehensive income (loss)			—						(337)						—						(337)
AOCI balance at beginning of period			—						698						—						698
Total other comprehensive income (loss)			—						(337)						—						(337)
AOCI balance at end of period			—						361						—						361

			Nine Months Ended September 30, 2023
$ in thousands			Equity method investments						Available-for-sale securities						Derivatives and hedging						Total
Total other comprehensive income (loss)
Unrealized gain (loss) on mortgage-backed securities, net			—						(698)						—						(698)
Reclassification of unrealized loss on available-for-sale securities to (increase) decrease in provision for credit losses			—						212						—						212
Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to repurchase agreements interest expense			—						—						(9,505)						(9,505)
Currency translation adjustments on investment in unconsolidated venture			(10)						—						—						(10)
Reclassification of currency translation loss on investment in unconsolidated venture to other investment income (loss), net			123						—						—						123
Total other comprehensive income (loss)			113						(486)						(9,505)						(9,878)
AOCI balance at beginning of period			(113)						469						10,405						10,761
Total other comprehensive income (loss)			113						(486)						(9,505)						(9,878)
AOCI balance at end of period			—						(17)						900						883

22

---

Table of Contents

Amounts recorded in AOCI before we discontinued cash flow hedge accounting for our interest rate swaps were reclassified to interest expense on the condensed consolidated statements of operations as interest was accrued and paid on the related repurchase agreements over the remaining original life of the interest rate swap agreements.

Dividends

The table below summarizes the dividends we declared during the nine months ended September 30, 2024 and 2023.

$ in thousands, except per share amounts			Dividends Declared
Series B Preferred Stock			Per Share						In Aggregate						Date of Payment
2024
August 7, 2024			0.4844						2,058						September 27, 2024
May 7, 2024			0.4844						2,058						June 27, 2024
February 21, 2024			0.4844						2,086						March 27, 2024
2023
August 2, 2023			0.4844						2,167						September 27, 2023
May 8, 2023			0.4844						2,186						June 27, 2023
February 17, 2023			0.4844						2,198						March 27, 2023

$ in thousands, except per share amounts			Dividends Declared
Series C Preferred Stock			Per Share						In Aggregate						Date of Payment
2024
August 7, 2024			0.46875						3,416						September 27, 2024
May 7, 2024			0.46875						3,450						June 27, 2024
February 21, 2024			0.46875						3,499						March 27, 2024
2023
August 2, 2023			0.46875						3,605						September 27, 2023
May 8, 2023			0.46875						3,654						June 27, 2023
February 17, 2023			0.46875						3,664						March 27, 2023

$ in thousands, except per share amounts			Dividends Declared
Common Stock			Per Share						In Aggregate						Date of Payment
2024
September 24, 2024			0.40						24,292						October 25, 2024
June 24, 2024			0.40						20,255						July 26, 2024
March 26, 2024			0.40						19,530						April 26, 2024
2023
September 26, 2023			0.40						19,384						October 27, 2023
June 21, 2023			0.40						17,833						July 27, 2023
March 27, 2023			0.40						16,658						April 27, 2023

23

---

Table of Contents

Note 13 – Earnings (Loss) per Common Share

Earnings (loss) per share for the three and nine months ended September 30, 2024 and 2023 is computed as shown in the table below.

			Three Months Ended September 30,												Nine Months Ended September 30,
In thousands, except per share amounts			2024						2023						2024						2023
Numerator (Income)
Basic Earnings:
Net income (loss) available to common stockholders			35,271						(74,024)						40,235						(59,821)
Denominator (Weighted Average Shares)
Basic Earnings:
Shares available to common stockholders			56,232						45,747						51,394						42,604
Effect of dilutive securities:
Restricted stock awards			1						—						1						—
Dilutive Shares			56,233						45,747						51,395						42,604
Earnings (loss) per share:
Net income (loss) attributable to common stockholders
Basic			0.63						(1.62)						0.78						(1.40)
Diluted			0.63						(1.62)						0.78						(1.40)

There were no weighted average common shares excluded from diluted earnings per share for the three months ended September 30, 2024 because the effect would be antidilutive (three and nine months ended September 30, 2023: 1,383 and 1,077 excluded for restricted stock awards, respectively).

Note 14 – Commitments and Contingencies

Commitments and contingencies may arise in the ordinary course of business. As of September 30, 2024, we were not aware of any reported or unreported contingencies.

Note 15 – Subsequent Events

Dividends

We declared the following dividends on November 4, 2024: a Series B Preferred Stock dividend of $0.4844 per share payable on December 27, 2024 to our stockholders of record as of December 5, 2024 and a Series C Preferred Stock dividend of $0.46875 per share payable on December 27, 2024 to our stockholders of record as of December 5, 2024.

Redemption of Series B Preferred Stock

On November 5, 2024, we announced that we intend to redeem all 4,247,989 outstanding shares of our 7.75% Fixed-to-Floating Series B Cumulative Redeemable Preferred Stock on December 27, 2024 for a cash redemption price of $25.00 per share, plus accrued and unpaid dividends (whether or not declared) to, but not including, the redemption date.

24

---

Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

In this quarterly report on Form 10-Q, or this "Quarterly Report," we refer to Invesco Mortgage Capital Inc. and its consolidated subsidiaries as "we," "us," "our Company," or "our," unless we specifically state otherwise or the context indicates otherwise. We refer to our external manager, Invesco Advisers, Inc., as our "Manager," and we refer to the indirect parent company of our Manager, Invesco Ltd. together with its consolidated subsidiaries (which does not include us), as "Invesco."

The following discussion should be read in conjunction with our condensed consolidated financial statements and the accompanying notes to our condensed consolidated financial statements, which are included in Item 1 of this Quarterly Report, as well as the information contained in our most recent Form 10-K filed with the Securities and Exchange Commission (the “SEC”).

Forward-Looking Statements

We make forward-looking statements in this Quarterly Report and other filings we make with the SEC within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and such statements are intended to be covered by the safe harbor provided by the same. Forward-looking statements are subject to substantial risks and uncertainties, many of which are difficult to predict and are generally beyond our control. These forward-looking statements include information about possible or assumed future results of our business, investment strategies, financial condition, liquidity, results of operations, plans, objectives and our views on domestic and global market conditions (including the mortgage-backed securities, residential and commercial real estate markets). When we use the words “believe,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “project,” “forecast” or similar expressions and future or conditional verbs such as “will,” “may,” “could,” “should,” and “would,” and any other statement that necessarily depends on future events, we intend to identify forward-looking statements, although not all forward-looking statements may contain such words.

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. You should not place undue reliance on these forward-looking statements. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us. We caution you not to rely unduly on any forward-looking statements and urge you to carefully consider the factors described under the headings "Risk Factors" and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in this Report and our Annual Report on Form 10-K. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made. New risks and uncertainties arise over time, and it is not possible for us to predict those events or how they may affect us. Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

25

---

Table of Contents

Executive Summary

We are a Maryland corporation primarily focused on investing in, financing and managing mortgage-backed securities (“MBS”) and other mortgage-related assets. Our objective is to provide attractive risk-adjusted returns to our stockholders, primarily through dividends and secondarily through capital appreciation.

As of September 30, 2024, we were invested in:

•residential mortgage-backed securities (“RMBS”) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association (“Ginnie Mae”), or a federally chartered corporation such as the Federal National Mortgage Association (“Fannie Mae” or “FNMA”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac” or “FHLMC”) (collectively “Agency RMBS”);

•commercial mortgage-backed securities ("CMBS") that are guaranteed by a U.S. government agency such as Ginnie Mae or a federally chartered corporation such as Freddie Mac or Fannie Mae (collectively “Agency CMBS”);

•CMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation (“non-Agency CMBS”); and

•RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation (“non-Agency RMBS”).

During the periods presented in this Quarterly Report, we also invested in:

• to-be-announced securities forward contracts (“TBAs”) to purchase Agency RMBS;

•U.S. Treasury securities; and

•other real estate-related financing arrangements in the form of unconsolidated ventures.

We continuously evaluate new investment opportunities to complement our current investment portfolio by expanding our target assets and portfolio diversification.

We conduct our business through our wholly-owned subsidiary, IAS Operating Partnership L.P. (the “Operating Partnership”). We are externally managed and advised by our Manager, an indirect wholly-owned subsidiary of Invesco.

We have elected to be taxed as a real estate investment trust (“REIT”) for U.S. federal income tax purposes under the provisions of the Internal Revenue Code of 1986. To maintain our REIT qualification, we are generally required to distribute at least 90% of our REIT taxable income to our stockholders annually. We operate our business in a manner that permits our exclusion from the definition of “Investment Company” under the 1940 Act.

26

---

Table of Contents

Market Conditions and Impacts

Macroeconomic factors that affect our business include inflation, economic growth, employment conditions, interest rates, interest rate volatility, fiscal and monetary policy, financial conditions, spread premiums, residential and commercial real estate prices, credit availability, the health of the banking system, consumer personal income and spending and corporate earnings. Of these macroeconomic factors, inflation, employment conditions, monetary policy, interest rates and interest rate volatility had the most direct impacts on our performance and financial condition during the third quarter of 2024.

Inflation readings trended lower during the quarter, moving closer to the Federal Reserve’s 2% inflation target. The headline consumer price index (“CPI”) ended the quarter at 2.4%, down from June’s 3.0%, while CPI (ex. food and energy) remained flat at 3.3%. Investors reacted positively to these readings, with expectations for future inflation adjusting lower and Treasury inflation-protected securities breakeven rates decreased. The two-year breakeven ended the quarter at 1.77% (down from 2.11% at the end of June) and the five-year breakeven ended at 2.09% (down from 2.28%). Meanwhile, employment data released during the quarter reflected a slowing labor market, as the economy added an average of 152 thousand jobs during July and August. Following the end of the quarter, the Bureau of Labor Statistics announced the nonfarm payrolls changed to 254 thousand in September.

Cooling inflation and softer employment data prior to the release of September payrolls led to a re-pricing of the market’s expectations of future monetary policy. Following the Federal Open Market Committee’s (“FOMC”) 50 basis point reduction of the Federal Funds target rate in September. In addition, Federal Funds futures market expectations as of September 30, 2024 reflected a further 175 to 200 basis point reduction of the target rate through the end of 2025. Quantitative tightening continued in the third quarter of 2024, as the Federal Reserve passively reduced the size of its balance sheet through maturities of U.S. Treasuries and paydowns of Agency RMBS. Paydowns of Agency RMBS from the balance sheet added approximately $17 billion of net supply to the market each month, well below the Federal Reserve's monthly cap of $35 billion. Although quantitative tightening is anticipated to conclude over the next several quarters, runoff of the Agency RMBS portion of the balance sheet is expected to continue, with proceeds redeployed into Treasuries.

Interest rates dropped sharply across the maturity spectrum, as investors reacted to potentially slower economic activity signaled by a weakening labor market. The yield on the two-year Treasury decreased 107 basis points to 3.65%, the yield on the five-year Treasury decreased 75 basis points to 3.58% and the yield on the ten-year Treasury finished at 3.80%, down 54 basis points on the quarter. Interest rate volatility increased through August before declining in the wake of the FOMC’s decision to begin easing monetary policy at their September meeting.

Against this macroeconomic backdrop, Agency RMBS outperformed Treasuries during the third quarter. Lower interest rate volatility increased demand for Agency RMBS, with lower coupons performing better than higher coupons as the sharp decline in interest rates impacted coupons trading at a premium to par. Prepayment speeds remained at very low levels given limited housing activity and elevated mortgage rates. Premiums on higher coupon specified pool collateral increased modestly given the decrease in interest rates. Implied financing via the dollar roll market for TBA investments remained relatively unattractive throughout the quarter. Agency CMBS risk premiums moved modestly wider.

Market Rates

			As of
			September 30, 2024						June 30, 2024						March 31, 2024						December 31, 2023						September 30, 2023												One Quarter Change						One Year Change
Interest Rates
Effective Federal Funds Rate			4.83		%				5.33		%				5.33		%				5.33		%				5.33		%										(0.50)		%				(0.50)		%
One-month SOFR			4.86		%				5.34		%				5.33		%				5.35		%				5.32		%										(0.48)		%				(0.46)		%
2 Year Treasury			3.65		%				4.72		%				4.62		%				4.25		%				5.04		%										(1.07)		%				(1.39)		%
5 Year Treasury			3.58		%				4.33		%				4.20		%				3.83		%				4.60		%										(0.75)		%				(1.02)		%
10 Year Treasury			3.80		%				4.34		%				4.19		%				3.86		%				4.57		%										(0.54)		%				(0.77)		%
30 Year Treasury			4.13		%				4.50		%				4.34		%				4.02		%				4.71		%										(0.37)		%				(0.58)		%

27

---

Table of Contents

			As of
(in basis points)			September 30, 2024						June 30, 2024						March 31, 2024						December 31, 2023						September 30, 2023												One Quarter Change						One Year Change
Swap Spreads (1)
2 Year			(20)						(15)						(8)						(18)						(7)												(5)						(13)
5 Year			(31)						(28)						(23)						(32)						(23)												(3)						(8)
10 Year			(47)						(42)						(37)						(40)						(30)												(5)						(17)
30 Year			(82)						(80)						(73)						(71)						(69)												(2)						(13)
30 Year Mortgage Spreads vs. 5/10 Year Treasury Blend (2)
FNMA 2.0%			70						62						62						55						63												8						7
FNMA 2.5%			76						68						68						65						71												8						5
FNMA 3.0%			81						74						75						73						77												7						4
FNMA 3.5%			86						80						80						81						85												6						1
FNMA 4.0%			96						91						89						95						96												5						—
FNMA 4.5%			110						101						102						110						107												9						3
FNMA 5.0%			132						116						118						131						125												16						7
FNMA 5.5%			137						138						138						154						144												(1)						(7)
FNMA 6.0%			107						157						153						165						164												(50)						(57)
10 Year Agency CMBS Spreads vs. Treasuries (3)
FHLMC K			48						49						54						60						74												(1)						(26)
FNMA DUS			58						54						58						67						78												4						(20)

(1)Swap spreads represent the difference between the fixed rate coupon of an interest rate swap and the yield on a U.S. Treasury security with a similar maturity.

(2)Mortgage spreads represent the difference between the yield on the Agency TBA and the blended average yield of five year and ten year U.S. Treasury securities.

(3)Agency CMBS spreads represent the difference between the yields on new issue Freddie Mac K Certificates and Fannie Mae Delegated Underwriting and Servicing MBS (“DUS”) and a U.S. Treasury security with a similar maturity.

Outlook

The recent disinflationary trend in economic data suggests that the Federal Reserve may continue to ease monetary policy in the coming months as the need for restrictive monetary policy declines. This easing should lead to a steeper yield curve and lower interest rate volatility, creating a favorable environment for Agency RMBS investments. However, if the disinflationary trend reverses and the labor market and economic growth improve, expectations for monetary policy could shift, posing a near-term risk. Additionally, short-term funding pressures into year end could reduce investor interest in the sector. Despite these near-term risks, we are constructive on the sector, as Agency mortgage performance stands to benefit from normalization of monetary policy given attractive valuations and supportive supply and demand technicals. We also remain constructive on Agency CMBS, as we expect a gradual increase in new issuance to be met with adequate investor demand, as the sector offers value relative to other fixed income investments, given its attractive prepayment protection and return profiles.

28

---

Table of Contents

Investment Activities

The table below shows the composition of our investment portfolio as of September 30, 2024, December 31, 2023 and September 30, 2023.

			As of
$ in thousands			September 30, 2024						December 31, 2023						September 30, 2023
Agency RMBS:
30 year fixed-rate pass-through, at fair value			5,107,814						4,952,474						5,331,969
Agency CMO, at fair value			73,199						74,758						78,007
Agency CMBS, at fair value			675,074						—						—
Non-Agency CMBS, at fair value			9,936						9,935						25,987
Non-Agency RMBS, at fair value			7,673						8,139						7,965
U.S. Treasury securities, at fair value			—						11,214						—
Investments in unconsolidated ventures			—						500						505
Total investment portfolio			5,873,696						5,057,020						5,444,433

As of September 30, 2024, our holdings of 30 year fixed-rate Agency RMBS represented approximately 87% of our total investment portfolio versus 98% as of December 31, 2023 and September 30, 2023. Our 30 year fixed-rate Agency RMBS holdings as of September 30, 2024, December 31, 2023 and September 30, 2023 consisted of specified pools with coupon distributions as shown in the table below.

						As of
						September 30, 2024																		December 31, 2023																		September 30, 2023
$ in thousands						Fair Value						Percentage						Period-end Weighted Average Yield						Fair Value						Percentage						Period-end Weighted Average Yield						Fair Value						Percentage						Period-end Weighted Average Yield
4.0%						577,105						11.3		%				4.66		%				876,337						17.7		%				4.65		%				1,218,869						22.9		%				4.64		%
4.5%						703,865						13.8		%				4.95		%				1,017,191						20.5		%				4.95		%				1,313,632						24.6		%				4.97		%
5.0%						1,147,475						22.5		%				5.27		%				1,028,036						20.8		%				5.34		%				1,424,615						26.7		%				5.32		%
5.5%						1,260,678						24.6		%				5.59		%				1,016,707						20.5		%				5.59		%				1,374,853						25.8		%				5.59		%
6.0%						1,418,691						27.8		%				5.98		%				1,014,203						20.5		%				6.03		%				—						—						—		%
Total 30 year fixed-rate Agency RMBS						5,107,814						100.0		%				5.43		%				4,952,474						100.0		%				5.33		%				5,331,969						100.0		%				5.15		%

Our purchases of Agency RMBS have been primarily focused on specified pools with attractive prepayment profiles. We seek to capitalize on the impact of prepayments on our investment portfolio by purchasing specified pools with characteristics that optimize borrower incentive to prepay for both our premium and discount priced investments. The table below shows the specified pool characteristics of our 30 year fixed-rate Agency RMBS holdings as of September 30, 2024, December 31, 2023 and September 30, 2023.

						As of
						September 30, 2024												December 31, 2023												September 30, 2023
$ in thousands						Fair Value						Percentage						Fair Value						Percentage						Fair Value						Percentage
Specified pool characteristic:
Geographic location						797,179						15.6		%				1,079,310						21.8		%				1,557,191						29.2		%
Loan balance						2,185,843						42.8		%				2,193,876						44.3		%				1,634,316						30.7		%
High loan-to-value ratio						792,248						15.5		%				574,246						11.6		%				1,012,827						19.0		%
Low credit score						1,332,544						26.1		%				1,105,042						22.3		%				1,127,635						21.1		%
Total 30 year fixed-rate Agency RMBS						5,107,814						100.0		%				4,952,474						100.0		%				5,331,969						100.0		%

29

---

Table of Contents

We resumed investing in fixed-rate Agency CMBS in the first quarter of 2024 because these securities benefit from prepayment protection characteristics and have an attractive return profile. Further, the hedging costs related to these holdings are economical as they are less sensitive to interest rate risk given prepayment protection and scheduled balloon maturity payments. As of September 30, 2024, our holdings of Agency CMBS represented approximately 11% of our total investment portfolio, and approximately 74% of our Agency CMBS were Fannie Mae DUS and 26% were Freddie Mac Multifamily Participation Certificates.

As of September 30, 2024, December 31, 2023 and September 30, 2023, our holdings of non-Agency CMBS and non-Agency RMBS represented less than 1% of our total investment portfolio. Approximately 68% of our non-Agency securities were rated double-A (or equivalent) or higher by a nationally recognized statistical rating organization as of September 30, 2024.

In the first quarter of 2024, we received a final distribution from our sole remaining unconsolidated venture. Following this distribution, we no longer have any investments in unconsolidated ventures.

Financing and Other Liabilities

We finance the majority of our investment portfolio through repurchase agreements. Repurchase agreements are generally settled on a short-term basis, usually from one to six months, and bear interest at rates that are expected to move in close relationship to the secured overnight financing rate (“SOFR”).

The following table presents the amount of collateralized borrowings outstanding under repurchase agreements as of the end of each quarter, the average amount outstanding during the quarter and the maximum balance outstanding during the quarter.

$ in thousands			Collateralized borrowings under repurchase agreements
Quarter Ended			Quarter-end balance						Average quarterly balance (1)						Maximum balance (2)
September 30, 2023			4,987,006						4,902,400						4,987,006
December 31, 2023			4,458,695						3,736,432						4,458,695
March 31, 2024			4,393,908						4,419,757						4,531,261
June 30, 2024			4,260,475						4,251,953						4,269,254
September 30, 2024			5,184,885						5,004,504						5,184,885

(1)Average quarterly balance for each period is based on month-end balances.

(2)Amount represents the maximum borrowings at month-end during each of the respective periods.

Hedging Instruments

We enter into interest rate swap agreements that are designed to mitigate the effects of changes in interest rates for a portion of our borrowings. Under these swap agreements, we generally pay fixed interest rates and receive floating interest rates indexed to SOFR. To a lesser extent, we have also used interest rate swap agreements whereby we make floating interest rate payments indexed to SOFR and receive fixed interest rate payments as part of our overall risk management strategy.

We actively manage our interest rate swap portfolio as the size and composition of our investment portfolio changes. During the nine months ended September 30, 2024, we entered into interest rate swaps with a notional amount of $2.6 billion and terminated existing interest rate swaps with a notional amount of $2.9 billion.

During the third quarter of 2024, we began entering into futures contracts comprised of short positions in Ultra 10 year U.S. Treasury Notes as an alternative way to help mitigate the potential impact of changes in interest rates on our performance. During the quarter, we entered into futures contracts with a notional amount of $750.0 million and terminated existing futures contracts with a notional amount of $260.0 million.

Daily variation margin for interest rate swaps and futures contracts is characterized as settlement of the derivative itself rather than collateral and is recorded as a realized gain or loss in our condensed consolidated statement of operations.

30

---

Table of Contents

Capital Activities

As of September 30, 2024, we had 12,089,398 shares of our common stock remaining available for sale from time to time in at-the-market or privately negotiated transactions under our equity distribution agreement with placement agents. The table below shows sales of our common stock under equity distribution agreements during the three and nine months ended September 30, 2024 and 2023.

						Three Months Ended September 30,												Nine Months Ended September 30,
Shares in ones, $ in thousands						2024						2023						2024						2023
Shares sold						10,084,138						3,880,763						12,211,131						9,699,471
Net proceeds						88,546						42,344						107,915						109,104
Commissions and other costs						1,261						575						1,515						1,478

For information on dividends declared during the nine months ended September 30, 2024 and 2023, see Note 12 - "Stockholders' Equity" of our condensed consolidated financial statements in Part I. Item 1 of this report on Form 10-Q.

During the nine months ended September 30, 2024, we did not repurchase any shares of our common stock.

In May 2022, our board of directors approved a share repurchase program for our Series B and Series C Preferred Stock. During the three and nine months ended September 30, 2024, we repurchased and retired no shares and 138,008 shares of Series B Preferred Stock, respectively, and 66,507 and 267,916 shares of Series C Preferred Stock, respectively. During the three and nine months ended September 30, 2023, we repurchased and retired 34,432 and 72,220 shares of Series B Preferred Stock, respectively, and 92,563 and 135,259 shares of Series C Preferred Stock, respectively. As of September 30, 2024, we had authority to repurchase 1,047,989 additional shares of our Series B Preferred Stock and 777,523 additional shares of our Series C Preferred Stock under the current preferred stock share repurchase program.

On November 5, 2024, we announced our intention to redeem all outstanding shares of our Series B Preferred Stock on December 27, 2024 for a cash redemption price of $25.00 per share, plus accrued and unpaid dividends. The redemption of the Series B Preferred Stock will help optimize our capital structure and reduce our dividend obligations moving forward.

Book Value per Common Share

We calculate book value per common share as follows.

			As of
In thousands except per share amounts			September 30, 2024						December 31, 2023
Numerator (adjusted equity):
Total equity			857,003						782,665
Less: Liquidation preference of Series B Preferred Stock			(106,200)						(109,650)
Less: Liquidation preference of Series C Preferred Stock			(181,938)						(188,636)
Total adjusted equity			568,865						484,379
Denominator (number of shares):
Common stock outstanding			60,730						48,461
Book value per common share			9.37						10.00

Our book value per common share decreased 6.3% as of September 30, 2024 compared to December 31, 2023. The decrease in our book value per common share occurred during the first half of 2024 as Agency RMBS modestly underperformed interest rate swaps. Our book value per common share rebounded slightly during the third quarter of 2024 as interest rates declined sharply and Agency RMBS outperformed interest rate swaps. Refer to Item 3. “Quantitative and Qualitative Disclosures About Market Risk” for interest rate risk and its impact on fair value.

31

---

Table of Contents

Critical Accounting Policies and Estimates

There have been no significant changes to our critical accounting policies and estimates that are disclosed in our most recent Form 10-K for the year ended December 31, 2023.

Recent Accounting Standards

None.

Results of Operations

The table below presents information from our condensed consolidated statements of operations for the three and nine months ended September 30, 2024 and 2023.

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands, except share data			2024						2023						2024						2023
Interest income			73,825						75,132						210,436						215,847
Interest expense			66,315						65,701						187,288						174,449
Net interest income			7,510						9,431						23,148						41,398
Other income (loss)
Gain (loss) on investments, net			165,168						(224,897)						53,803						(272,620)
(Increase) decrease in provision for credit losses			80						(43)						(222)						(212)
Equity in earnings (losses) of unconsolidated ventures			—						2						(193)						4
Gain (loss) on derivative instruments, net			(127,345)						151,689						(5,922)						203,418
Other investment income (loss), net			—						—						—						(66)
Total other income (loss)			37,903						(73,249)						47,466						(69,476)
Expenses
Management fee – related party			2,888						3,090						8,694						9,237
General and administrative			1,805						1,691						5,544						5,743
Total expenses			4,693						4,781						14,238						14,980
Net income (loss)			40,720						(68,599)						56,376						(43,058)
Dividends to preferred stockholders			(5,474)						(5,772)						(16,567)						(17,474)
Gain on repurchase and retirement of preferred stock			25						347						426						711
Net income (loss) attributable to common stockholders			35,271						(74,024)						40,235						(59,821)
Earnings (loss) per share:
Net income (loss) attributable to common stockholders
Basic			0.63						(1.62)						0.78						(1.40)
Diluted			0.63						(1.62)						0.78						(1.40)
Weighted average number of shares of common stock:
Basic			56,231,850						45,746,840						51,394,067						42,604,379
Diluted			56,233,031						45,746,840						51,395,488						42,604,379

32

---

Table of Contents

Interest Income and Average Earning Asset Yields

The table below presents information related to our average earning assets and earning asset yields for the three and nine months ended September 30, 2024 and 2023.

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands			2024						2023						2024						2023
Average earning assets (1)			5,566,299						5,498,298						5,130,153						5,344,055
Average earning asset yields (2)			5.31		%				5.47		%				5.47		%				5.39		%

(1)Average balances for each period are based on weighted month-end balances.

(2)Average earning asset yields for the period were calculated by dividing interest income, including amortization of premiums and discounts, by average earning assets based on the amortized cost of the investments. All yields are annualized.

Total average earning assets increased $68.0 million and decreased $213.9 million for the three and nine months ended September 30, 2024 compared to the same periods in 2023, respectively. Changes in our average earning assets are a factor of our total stockholders' equity and our desired leverage levels.

Average earning asset yields decreased 16 basis points and increased 8 basis points for the three and nine months ended September 30, 2024 compared to the same periods in 2023, respectively. Changes in our average earning assets yields are driven by our coupon allocation to Agency RMBS and the book prices of our securities.

We earned total interest income of $73.8 million and $210.4 million for the three and nine months ended September 30, 2024, respectively (September 30, 2023: $75.1 million and $215.8 million). Our interest income includes coupon interest and net (premium amortization) discount accretion as shown in the table below.

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands			2024						2023						2024						2023
Interest Income
Coupon interest			72,348						72,200						206,037						211,435
Net (premium amortization) discount accretion			1,477						2,932						4,399						4,412
Total interest income			73,825						75,132						210,436						215,847

Our interest income was relatively flat for the three months ended September 30, 2024 compared to the same period in 2023 as a decrease in average earning asset yields was largely offset by an increase in average earning assets. Our interest income decreased $5.4 million for the nine months ended September 30, 2024 compared to the same period in 2023 as a decrease in average earning assets was partially offset by an increase in average earning asset yields.

Prepayment Speeds

Our RMBS portfolio is subject to inherent prepayment risk primarily driven by changes in interest rates, which impacts the amount of premium and discount on the purchase of these securities that is recognized into interest income. Generally, in an environment of falling interest rates, prepayment speeds will increase as homeowners are more likely to prepay their existing mortgage and refinance into a lower borrowing rate. In an environment of rising interest rates, prepayment speeds will generally decrease as homeowners are not as incentivized to refinance. For Agency RMBS where we do not estimate prepayments, premium amortization and discount accretion are not impacted by prepayments until actual prepayments occur. For those securities on which we do estimate prepayments, expected future prepayment speeds are estimated on a quarterly basis. If the actual prepayment speed during the period is faster than estimated, the amortization on securities purchased at a premium to par value will be accelerated, resulting in lower interest income recognized. Conversely, for securities purchased at a discount to par value, interest income will be reduced in periods where prepayment speeds were slower than expected.

33

---

Table of Contents

The following table presents net (premium amortization) discount accretion recognized for the three and nine months ended September 30, 2024 and 2023.

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands			2024						2023						2024						2023
Agency RMBS			1,298						2,465						4,028						3,616
Agency CMBS			168						—						338						—
Non-Agency CMBS			114						301						372						888
Non-Agency RMBS			(103)						(126)						(338)						(384)
U.S. Treasury Securities			—						292						(1)						292
Net (premium amortization) discount accretion			1,477						2,932						4,399						4,412

Net discount accretion decreased for three months ended September 30, 2024 compared to the same period in 2023 as our portfolio was repositioned into securities with higher book prices. Net discount accretion was relatively flat for nine months ended September 30, 2024 compared to the same period in 2023 as higher discount accretion in the earlier part of 2024 was offset by our portfolio repositioning into securities with higher book prices.

Our interest income is subject to interest rate risk. Refer to Item 3. "Quantitative and Qualitative Disclosures about Market Risk" for more information relating to interest rate risk and its impact on our operating results.

Interest Expense and Cost of Funds

The table below presents information related to our borrowings and cost of funds for the three and nine months ended September 30, 2024 and 2023.

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands			2024						2023						2024						2023
Total average borrowings (1)			5,004,504						4,902,400						4,560,365						4,811,136
Maximum borrowings during the period (2)			5,184,885						4,987,006						5,184,885						4,987,006
Cost of funds (3)			5.30		%				5.36		%				5.48		%				4.83		%

(1)Average borrowings for each period are based on weighted month-end balances.

(2)Amount represents the maximum borrowings at month-end during each of the respective periods.

(3)Average cost of funds is calculated by dividing annualized interest expense including amortization of net deferred gain (loss) on de-designated interest rate swaps by our average borrowings.

Total average borrowings increased $102.1 million and decreased $250.8 million for the three and nine months ended September 30, 2024 compared to the same periods in 2023, respectively. Changes in our average borrowings are a factor of our total stockholders' equity and our desired leverage levels.

Our average cost of funds decreased 6 basis points and increased 65 basis points for the three and nine months ended September 30, 2024 compared to the same periods in 2023, respectively. Changes in our costs of funds are substantially driven by the Federal Funds target rate, which the FOMC raised from a range of 4.25% to 4.50% as of January 1, 2023 to a maximum of 5.25% to 5.50%, before lowering the target rate to 4.75% to 5.00% in September 2024. Our cost of funds for the three and nine months ended September 30, 2024 was also significantly impacted by a decrease in amortization of net deferred gains on de-designated interest rate swaps. The amortization of these gains ended in December 2023.

34

---

Table of Contents

The table below presents the components of interest expense for the three and nine months ended September 30, 2024 and 2023.

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands			2024						2023						2024						2023
Interest Expense
Interest expense on repurchase agreement borrowings			66,315						67,511						187,288						183,954
Amortization of net deferred (gain) loss on de-designated interest rate swaps			—						(1,810)						—						(9,505)
Total interest expense			66,315						65,701						187,288						174,449

Our interest expense was relatively flat for the three months ended September 30, 2024 compared to the same period in 2023 as a decrease in contractual interest expense on our repurchase agreements was offset by a decrease in amortization of net deferred gains on de-designated interest rate swaps. Our interest expense increased $12.8 million for the nine months ended September 30, 2024 compared to the same period in 2023 due to a decrease in amortization of net deferred gains on de-designated interest rate swaps and increases in borrowing rates that more than offset decreases in our average borrowings.

Amounts recorded in accumulated other comprehensive income before we discontinued cash flow hedge accounting for our interest rate swaps were reclassified to interest expense on the condensed consolidated statements of operations as interest was accrued and paid on the related repurchase agreements over the remaining life of the interest rate swap agreements.

Net Interest Income

The table below presents the components of net interest income for the three and nine months ended September 30, 2024 and 2023.

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands			2024						2023						2024						2023
Interest income			73,825						75,132						210,436						215,847
Interest Expense:
Interest expense on repurchase agreement borrowings			66,315						67,511						187,288						183,954
Amortization of net deferred (gain) loss on de-designated interest rate swaps			—						(1,810)						—						(9,505)
Total interest expense			66,315						65,701						187,288						174,449
Net interest income			7,510						9,431						23,148						41,398
Net interest rate margin			0.01		%				0.11		%				(0.01)		%				0.56		%

Our net interest income, which equals total interest income less total interest expense, totaled $7.5 million and $23.1 million for the three and nine months ended September 30, 2024, respectively (September 30, 2023: $9.4 million and $41.4 million). The decrease in net interest income for the three months ended September 30, 2024 compared to the same period in 2023 was primarily due to lower average earning asset yields, which was partially offset by higher average earning assets. The decrease in net interest income for the nine months ended September 30, 2024 compared to the same period in 2023 was primarily due to a decrease in amortization of net deferred gains on de-designated interest rate swaps and increases in the Federal Funds target rate, which were partially offset by lower average borrowings.

Our net interest rate margin, which equals the yield on our average assets for the period less the average cost of funds, decreased in the three months ended September 30, 2024 compared the same period in 2023 due to decreases in average earning asset yields. Our net interest rate margin decreased in the nine months ended September 30, 2024 due to increases in the Federal Funds target rate and decreases in amortization of net deferred gains on de-designated interest rate swaps. Our cost of funds is generally more sensitive to changes in interest rates than the yield on our investment portfolio, which is largely comprised of 30 year fixed-rate Agency RMBS.

35

---

Table of Contents

Gain (Loss) on Investments, net

The table below summarizes the components of gain (loss) on investments, net for the three and nine months ended September 30, 2024 and 2023.

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands			2024						2023						2024						2023
Net realized gains (losses) on sale of MBS			4,963						(33,157)						(4,787)						(57,406)
Net unrealized gains (losses) on MBS accounted for under the fair value option			160,205						(191,752)						59,048						(215,226)
Net unrealized gains (losses) on U.S. Treasury securities			—						—						(372)						—
Net realized gains (losses) on U.S. Treasury securities			—						12						(86)						12
Total gain (loss) on investments, net			165,168						(224,897)						53,803						(272,620)

During the three and nine months ended September 30, 2024, we sold MBS and realized net gains of $5.0 million and net losses of $4.8 million, respectively (September 30, 2023: net losses of $33.2 million and $57.4 million). Net realized gains and losses during the three and nine months ended September 30, 2024 primarily reflect sales of 4.0% to 5.0% coupon Agency RMBS with a portion of the proceeds being used to purchase Agency CMBS. Net realized losses during the three and nine months ended September 30, 2023 primarily reflect the repositioning of Agency RMBS coupon allocations and sales of lower yielding Agency RMBS to purchase higher yielding Agency RMBS in an effort to improve the earnings power of the portfolio.

We have elected the fair value option for all of our MBS purchased on or after September 1, 2016. Before September 1, 2016, we had also elected the fair value option for our non-Agency RMBS interest-only securities. Under the fair value option, changes in fair value are recognized in income in the condensed consolidated statements of operations. As of September 30, 2024, $5.9 billion (December 31, 2023: $5.0 billion) or 99.7% (December 31, 2023: 99.7%) of our MBS were accounted for under the fair value option.

We recorded net unrealized gains on our MBS portfolio accounted for under the fair value option of $160.2 million and $59.0 million in the three and nine months ended September 30, 2024 compared to net unrealized losses of $191.8 million and $215.2 million in the three and nine months ended September 30, 2023. Net unrealized gains in the three and nine months ended September 30, 2024 were due to lower interest rates during the third quarter resulting in improved valuations on Agency RMBS and Agency CMBS. Net unrealized losses in the three and nine months ended September 30, 2023 were primarily due to lower valuations on our Agency RMBS given higher interest rates and wider interest rate spreads on our holdings.

We recorded net realized and unrealized losses of $458,000 on U.S. Treasury securities in the nine months ended September 30, 2024. We sold the security during the first quarter of 2024.

(Increase) Decrease in Provision for Credit Losses

As of September 30, 2024, $15.4 million of our MBS are classified as available-for-sale and subject to evaluation for credit losses (December 31, 2023: $15.7 million). During the three and nine months ended September 30, 2024, we recorded a decrease of $80,000 and an increase of $222,000 in the provision for credit losses, respectively, on a single non-Agency CMBS. We recorded a $43,000 and $212,000 increase in the provision for credit losses during the three and nine months ended September 30, 2023, respectively, on the same security. Increases and decreases in the provision are based on a comparison of the security's amortized cost basis to discounted expected cash flows.

Equity in Earnings (Losses) of Unconsolidated Ventures

For the nine months ended September 30, 2024 we recorded equity in losses of unconsolidated ventures of $193,000 (three and nine months ended September 30, 2023: equity in earnings of $2,000 and $4,000, respectively). We received a final distribution from our sole remaining unconsolidated venture during the first quarter of 2024, and the venture was dissolved in April 2024.

36

---

Table of Contents

Gain (Loss) on Derivative Instruments, net

We record all derivatives on our condensed consolidated balance sheets at fair value. Changes in the fair value of our derivatives are recorded in gain (loss) on derivative instruments, net in our condensed consolidated statements of operations. Net interest paid or received under our interest rate swaps is also recognized in gain (loss) on derivative instruments, net in our condensed consolidated statements of operations.

The tables below summarize our realized and unrealized gain (loss) on derivative instruments, net for the following periods.

$ in thousands						Three months ended September 30, 2024
Derivative not designated as hedging instrument						Realized gain (loss) on derivative instruments, net						Contractual net interest income (expense)						Unrealized gain (loss), net						Gain (loss) on derivative instruments, net
Interest Rate Swaps						(160,472)						40,883						517						(119,072)
Futures Contracts						(12,419)						—						2,527						(9,892)
TBAs						94						—						1,525						1,619
Total						(172,797)						40,883						4,569						(127,345)

$ in thousands						Three months ended September 30, 2023
Derivative not designated as hedging instrument						Realized gain (loss) on derivative instruments, net						Contractual net interest income (expense)						Unrealized gain (loss), net						Gain (loss) on derivative instruments, net
Interest Rate Swaps						84,565						72,126						(5,002)						151,689
Total						84,565						72,126						(5,002)						151,689

$ in thousands						Nine months ended September 30, 2024
Derivative not designated as hedging instrument						Realized gain (loss) on derivative instruments, net						Contractual net interest income (expense)						Unrealized gain (loss), net						Gain (loss) on derivative instruments, net
Interest Rate Swaps						(134,661)						129,441						8,569						3,349
Futures Contracts						(12,419)						—						2,527						(9,892)
TBAs						621						—						—						621
Total						(146,459)						129,441						11,096						(5,922)

$ in thousands						Nine months ended September 30, 2023
Derivative not designated as hedging instrument						Realized gain (loss) on derivative instruments, net						Contractual net interest income (expense)						Unrealized gain (loss), net						Gain (loss) on derivative instruments, net
Interest Rate Swaps						21,509						190,027						(7,658)						203,878
Currency Forward Contracts						(18)						—						—						(18)
TBAs						(1,880)						—						1,438						(442)
Total						19,611						190,027						(6,220)						203,418

During the nine months ended September 30, 2024, we entered into interest rate swaps with a notional amount of $2.6 billion and terminated existing interest rate swaps with a notional amount of $2.9 billion. We recorded net losses of $119.1 million and net gains of $3.3 million on interest rate swaps for the three and nine months ended September 30, 2024, respectively, (September 30, 2023: net gains of $151.7 million and $203.9 million) primarily due to changes in forward interest rate expectations.

37

---

Table of Contents

As of September 30, 2024 and December 31, 2023, we held the following interest rate swaps whereby we pay fixed rate interest and receive floating rate interest based upon SOFR.

$ in thousands						As of September 30, 2024																								As of December 31, 2023
Derivative instrument						Notional Amount						Weighted Average Fixed Pay Rate						Weighted Average Floating Receive Rate						Weighted Average Years to Maturity						Notional Amount						Weighted Average Fixed Pay Rate						Weighted Average Floating Receive Rate						Weighted Average Years to Maturity
Interest Rate Swaps						3,790,000						1.37		%				4.96		%				5.4						4,065,000						1.10		%				5.38		%				6.6

As of September 30, 2024, we had $5.2 billion of repurchase agreement borrowings with a weighted average remaining maturity of 32 days. We typically refinance each repurchase agreement at market interest rates upon maturity. We use interest rate swaps to manage our exposure to changing interest rates and add stability to interest rate expense.

During the third quarter of 2024, we began using futures contracts as an alternative way to help mitigate the potential impact of changes in interest rates on our performance. During the three and nine months ended September 30, 2024, we entered into futures contracts with a notional amount of $750.0 million and terminated existing futures contracts with a notional amount of $260.0 million. We recognized net losses of $9.9 million on futures contracts during the three and nine months ended September 30, 2024 due to changes in forward interest rate expectations.

We primarily use TBAs that we do not intend to physically settle on the contractual settlement date as an alternative means of investing in and financing Agency RMBS. We recorded net gains of $1.6 million and $621,000 on TBAs during the three and nine months ended September 30, 2024, respectively (nine months ended September 30, 2023: net losses of $442,000).

Other Investment Income (Loss), net

Our other investment income (loss), net during the nine months ended September 30, 2023 consisted of foreign currency transaction gains and losses and the reclassification of our foreign currency translation adjustment that was previously recorded in accumulated other comprehensive income related to an unconsolidated venture that was liquidated during the first quarter of 2023.

Expenses

We incurred management fees of $2.9 million and $8.7 million for the three and nine months ended September 30, 2024, respectively (September 30, 2023: $3.1 million and $9.2 million). Management fees decreased for the three and nine months ended September 30, 2024 compared to the same period in 2023 due to a lower stockholders' equity management fee base. Refer to Note 11 – "Related Party Transactions" of our condensed consolidated financial statements for a discussion of our relationship with our Manager and a description of how our fees are calculated.

Our general and administrative expenses not covered under our management agreement amounted to $1.8 million and $5.5 million for the three and nine months ended September 30, 2024, respectively (September 30, 2023: $1.7 million and $5.7 million). General and administrative expenses not covered under our management agreement primarily consist of directors and officers insurance, legal costs, accounting, auditing and tax services, filing fees and miscellaneous general and administrative costs.

Gain on Repurchase and Retirement of Preferred Stock

In May 2022, our board of directors approved a share repurchase program for our Series B and Series C Preferred Stock. During the three and nine months ended September 30, 2024, we repurchased and retired no shares and 138,008 shares of Series B Preferred Stock, respectively, and 66,507 and 267,916 shares of Series C Preferred Stock, respectively. During the three and nine months ended September 30, 2023, we repurchased and retired 34,432 and 72,220 shares of Series B Preferred Stock, respectively, and 92,563 and 135,259 shares of Series C Preferred Stock, respectively. Gains on repurchases and retirements of preferred stock represent the difference between the consideration transferred and the carrying value of the preferred stock.

38

---

Table of Contents

Net Income (Loss) attributable to Common Stockholders

For the three months ended September 30, 2024, our net income attributable to common stockholders was $35.3 million (September 30, 2023: net loss of $74.0 million) or $0.63 basic and diluted net income per average share available to common stockholders (September 30, 2023: $1.62 net loss per share). The change in net income (loss) attributable to common stockholders was primarily due to (i) net gains on investments of $165.2 million in the 2024 period compared to net losses on investments of $224.9 million in the 2023 period; (ii) net losses on derivative instruments of $127.3 million in the 2024 period compared to net gains on derivatives of $151.7 million in the 2023 period; and (iii) a $1.9 million decrease in net interest income.

For the nine months ended September 30, 2024, our net income attributable to common stockholders was $40.2 million (September 30, 2023: net loss of $59.8 million) or $0.78 basic and diluted net income per average share available to common stockholders (September 30, 2023: $1.40 net loss per share). The change in net income (loss) attributable to common stockholders was primarily due to (i) net gains on investments of $53.8 million in the 2024 period compared to net losses on investments of $272.6 million in the 2023 period; (ii) net losses on derivative instruments of $5.9 million in the 2024 period compared to net gains on derivative instruments of $203.4 million in the 2023 period; and (iii) a $18.3 million decrease in net interest income.

For further information on the changes in net gain (loss) on derivative instruments, net gain (loss) on investments and changes in net interest income, see preceding discussion under “Gain (Loss) on Investments, net”, “Gain (Loss) on Derivative Instruments, net” and “Net Interest Income”.

Non-GAAP Financial Measures

The table below shows the non-GAAP financial measures we use to analyze our operating results and the most directly comparable U.S. GAAP measures. We believe these non-GAAP measures are useful to investors in assessing our performance as discussed further below.

Non-GAAP Financial Measure						Most Directly Comparable U.S. GAAP Measure
Earnings available for distribution (and by calculation, earnings available for distribution per common share)						Net income (loss) attributable to common stockholders (and by calculation, basic earnings (loss) per common share)
Effective interest expense (and by calculation, effective cost of funds)						Total interest expense (and by calculation, cost of funds)
Effective net interest income (and by calculation, effective interest rate margin)						Net interest income (and by calculation, net interest rate margin)
Economic debt-to-equity ratio						Debt-to-equity ratio

The non-GAAP financial measures used by management should be analyzed in conjunction with U.S. GAAP financial measures and should not be considered substitutes for U.S. GAAP financial measures. In addition, the non-GAAP financial measures may not be comparable to similarly titled non-GAAP financial measures of our peer companies.

Earnings Available for Distribution

Our business objective is to provide attractive risk-adjusted returns to our stockholders, primarily through dividends and secondarily through capital appreciation. We use earnings available for distribution as a measure of our investment portfolio’s ability to generate income for distribution to common stockholders and to evaluate our progress toward meeting this objective. We calculate earnings available for distribution as U.S. GAAP net income (loss) attributable to common stockholders adjusted for (gain) loss on investments, net; realized (gain) loss on derivative instruments, net; unrealized (gain) loss on derivative instruments, net; TBA dollar roll income; gain on repurchase and retirement of preferred stock; foreign currency (gains) losses, net and amortization of net deferred (gain) loss on de-designated interest rate swaps.

By excluding the gains and losses discussed above, we believe the presentation of earnings available for distribution provides a consistent measure of operating performance that investors can use to evaluate our results over multiple reporting periods and, to a certain extent, compare to our peer companies. However, because not all of our peer companies use identical operating performance measures, our presentation of earnings available for distribution may not be comparable to other similarly titled measures used by our peer companies. We exclude the impact of gains and losses when calculating earnings available for distribution because (i) when analyzed in conjunction with our U.S. GAAP results, earnings available for distribution provides additional detail of our investment portfolio’s earnings capacity and (ii) gains and losses are not accounted for consistently under U.S. GAAP. Under U.S. GAAP, certain gains and losses are reflected in net income whereas other gains and losses are reflected in other comprehensive income. For example, a portion of our mortgage-backed securities are classified

39

---

Table of Contents

as available-for-sale securities, and we record changes in the valuation of these securities in other comprehensive income on our condensed consolidated balance sheets. We elected the fair value option for our mortgage-backed securities purchased on or after September 1, 2016, and changes in the valuation of these securities are recorded in other income (loss) in our condensed consolidated statements of operations. In addition, certain gains and losses represent one-time events. We may add and have added additional reconciling items to our earnings available for distribution calculation as appropriate.

To maintain our qualification as a REIT, U.S. federal income tax law generally requires that we distribute at least 90% of our REIT taxable income annually, determined without regard to the deduction for dividends paid and excluding net capital gains. We have historically distributed at least 100% of our REIT taxable income. Because we view earnings available for distribution as a consistent measure of our investment portfolio's ability to generate income for distribution to common stockholders, earnings available for distribution is one metric, but not the exclusive metric, that our board of directors uses to determine the amount, if any, and the payment date of dividends on our common stock. However, earnings available for distribution should not be considered as an indication of our taxable income, a guaranty of our ability to pay dividends or as a proxy for the amount of dividends we may pay, as earnings available for distribution excludes certain items that impact our cash needs.

Earnings available for distribution is an incomplete measure of our financial performance and there are other factors that impact the achievement of our business objective. We caution that earnings available for distribution should not be considered as an alternative to net income (determined in accordance with U.S. GAAP) or as an indication of our cash flow from operating activities (determined in accordance with U.S. GAAP), a measure of our liquidity or as an indication of amounts available to fund our cash needs.

40

---

Table of Contents

The table below provides a reconciliation of U.S. GAAP net income (loss) attributable to common stockholders to earnings available for distribution for the following periods.

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands, except per share data			2024						2023						2024						2023
Net income (loss) attributable to common stockholders			35,271						(74,024)						40,235						(59,821)
Adjustments:
(Gain) loss on investments, net			(165,168)						224,897						(53,803)						272,620
Realized (gain) loss on derivative instruments, net (1)			172,797						(84,565)						146,459						(19,611)
Unrealized (gain) loss on derivative instruments, net (1)			(4,569)						5,002						(11,096)						6,220
TBA dollar roll income (2)			39						—						1,117						697
Gain on repurchase and retirement of preferred stock			(25)						(347)						(426)						(711)
Foreign currency (gains) losses, net (3)			—						—						—						66
Amortization of net deferred (gain) loss on de-designated interest rate swaps (4)			—						(1,810)						—						(9,505)
Subtotal			3,074						143,177						82,251						249,776
Earnings available for distribution			38,345						69,153						122,486						189,955
Basic income (loss) per common share			0.63						(1.62)						0.78						(1.40)
Earnings available for distribution per common share (5)			0.68						1.51						2.38						4.46

(1)U.S. GAAP gain (loss) on derivative instruments, net on the condensed consolidated statements of operations includes the following components.

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands			2024						2023						2024						2023
Realized gain (loss) on derivative instruments, net			(172,797)						84,565						(146,459)						19,611
Unrealized gain (loss) on derivative instruments, net			4,569						(5,002)						11,096						(6,220)
Contractual net interest income (expense) on interest rate swaps			40,883						72,126						129,441						190,027
Gain (loss) on derivative instruments, net			(127,345)						151,689						(5,922)						203,418

(2)A TBA dollar roll is a series of derivative transactions where TBAs with the same specified issuer, term and coupon but different settlement dates are simultaneously bought and sold. The TBA settling in the later month typically prices at a discount to the TBA settling in the earlier month. TBA dollar roll income represents the price differential between the TBA price for current month settlement versus the TBA price for forward month settlement. We include TBA dollar roll income in earnings available for distribution because it is the economic equivalent of interest income on the underlying Agency RMBS, less an implied financing cost, over the forward settlement period. TBA dollar roll income is a component of gain (loss) on derivative instruments, net on our condensed consolidated statements of operations.

(3)Foreign currency gains (losses), net includes foreign currency transaction gains and losses and the reclassification of currency translation adjustments that were previously recorded in accumulated other comprehensive income and is included in other investment income (loss), net on the condensed consolidated statements of operations.

(4)U.S. GAAP interest expense on the condensed consolidated statements of operations includes the following components.

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands			2024						2023						2024						2023
Interest expense on repurchase agreement borrowings			66,315						67,511						187,288						183,954
Amortization of net deferred (gain) loss on de-designated interest rate swaps			—						(1,810)						—						(9,505)
Total interest expense			66,315						65,701						187,288						174,449

(5)Earnings available for distribution per common share is equal to earnings available for distribution divided by the basic weighted average number of common shares outstanding.

41

---

Table of Contents

The table below shows the components of earnings available for distribution for the following periods.

			Three Months Ended September 30,												Nine Months Ended September 30,
$ in thousands			2024						2023						2024						2023
Effective net interest income (1)			48,393						79,747						152,589						221,920
TBA dollar roll income			39						—						1,117						697
Equity in earnings (losses) of unconsolidated ventures			—						2						(193)						4
(Increase) decrease in provision for credit losses			80						(43)						(222)						(212)
Total expenses			(4,693)						(4,781)						(14,238)						(14,980)
Subtotal			43,819						74,925						139,053						207,429
Dividends to preferred stockholders			(5,474)						(5,772)						(16,567)						(17,474)
Earnings available for distribution			38,345						69,153						122,486						189,955

(1)See below for a reconciliation of net interest income to effective net interest income, a non-GAAP measure.

Earnings available for distribution decreased during the three and nine months ended September 30, 2024 compared to the same periods in 2023 due to lower effective net interest income. See below for details on the change in effective net interest income.

Effective Interest Expense / Effective Cost of Funds / Effective Net Interest Income / Effective Interest Rate Margin

We calculate effective interest expense (and by calculation, effective cost of funds) as U.S. GAAP total interest expense adjusted for contractual net interest income (expense) on our interest rate swaps that is recorded as gain (loss) on derivative instruments, net and the amortization of net deferred gains (losses) on de-designated interest rate swaps that is recorded as interest expense. We view our interest rate swaps as an economic hedge against increases in future market interest rates on our borrowings. We add back the net payments or receipts on our interest rate swap agreements to our total U.S. GAAP interest expense because we use interest rate swaps to add stability to interest expense. We exclude the amortization of net deferred gains (losses) on de-designated interest rate swaps from our calculation of effective interest expense because we do not consider the amortization a current component of our borrowing costs.

We calculate effective net interest income (and by calculation, effective interest rate margin) as U.S. GAAP net interest income adjusted for contractual net interest income (expense) on our interest rate swaps that is recorded as gain (loss) on derivative instruments, net and amortization of net deferred gains (losses) on de-designated interest rate swaps that is recorded as interest expense.

We believe the presentation of effective interest expense, effective cost of funds, effective net interest income and effective interest rate margin measures, when considered together with U.S. GAAP financial measures, provides information that is useful to investors in understanding our borrowing costs and operating performance.

42

---

Table of Contents

The following table reconciles total interest expense to effective interest expense and cost of funds to effective cost of funds for the following periods.

			Three Months Ended September 30,
			2024												2023
$ in thousands			Reconciliation						Cost of Funds / Effective Cost of Funds						Reconciliation						Cost of Funds / Effective Cost of Funds
Total interest expense			66,315						5.30		%				65,701						5.36		%
Add: Amortization of net deferred gain (loss) on de-designated interest rate swaps			—						—		%				1,810						0.15		%
Less: Contractual net interest expense (income) on interest rate swaps recorded as gain (loss) on derivative instruments, net			(40,883)						(3.27)		%				(72,126)						(5.88)		%
Effective interest expense			25,432						2.03		%				(4,615)						(0.37)		%

			Nine Months Ended September 30,
			2024												2023
$ in thousands			Reconciliation						Cost of Funds / Effective Cost of Funds						Reconciliation						Cost of Funds / Effective Cost of Funds
Total interest expense			187,288						5.48		%				174,449						4.83		%
Add: Amortization of net deferred gain (loss) on de-designated interest rate swaps			—						—		%				9,505						0.26		%
Less: Contractual net interest expense (income) on interest rate swaps recorded as gain (loss) on derivative instruments, net			(129,441)						(3.78)		%				(190,027)						(5.27)		%
Effective interest expense			57,847						1.70		%				(6,073)						(0.18)		%

Our effective interest expense and effective cost of funds increased in the three and nine months ended September 30, 2024 compared to the same periods in 2023 due to decreases in contractual net interest income on interest rate swaps.

In addition to changes caused by the underlying floating rate index, the amount of contractual net interest income or expense on interest rate swaps that we recognize has changed based on changes in the size and composition of our interest rate swap portfolio. During the third quarter of 2024, we also began using futures contracts, which do not earn or incur contractual interest, in lieu of certain interest rate swaps as an alternative way to help mitigate the potential impact of changing interest rates on our performance. See preceding discussion under “Gain (Loss) on Derivative Instruments, net” for details of our interest rate swap portfolio as of September 30, 2024 and December 31, 2023.

43

---

Table of Contents

The following table reconciles net interest income to effective net interest income and net interest rate margin to effective interest rate margin for the following periods.

			Three Months Ended September 30,
			2024												2023
$ in thousands			Reconciliation						Net Interest Rate Margin / Effective Interest Rate Margin						Reconciliation						Net Interest Rate Margin / Effective Interest Rate Margin
Net interest income			7,510						0.01		%				9,431						0.11		%
Less: Amortization of net deferred (gain) loss on de-designated interest rate swaps			—						—		%				(1,810)						(0.15)		%
Add: Contractual net interest income (expense) on interest rate swaps recorded as gain (loss) on derivative instruments, net			40,883						3.27		%				72,126						5.88		%
Effective net interest income			48,393						3.28		%				79,747						5.84		%

			Nine Months Ended September 30,
			2024												2023
$ in thousands			Reconciliation						Net Interest Rate Margin / Effective Interest Rate Margin						Reconciliation						Net Interest Rate Margin / Effective Interest Rate Margin
Net interest income			23,148						(0.01)		%				41,398						0.56		%
Less: Amortization of net deferred (gain) loss on de-designated interest rate swaps			—						—		%				(9,505)						(0.26)		%
Add: Contractual net interest income (expense) on interest rate swaps recorded as gain (loss) on derivative instruments, net			129,441						3.78		%				190,027						5.27		%
Effective net interest income			152,589						3.77		%				221,920						5.57		%

Our effective net interest income and effective interest rate margin decreased in the three months ended September 30, 2024 compared to the same period in 2023 due to decreases in contractual net interest income on interest rate swaps. Our effective net interest income and effective interest rate margin decreased in the nine months ended September 30, 2024 compared to the same period in 2023 due to decreases in contractual net interest income on interest rate swaps and increases in the Federal Funds target rate.

44

---

Table of Contents

Economic Debt-to-Equity Ratio

The tables below show the allocation of our stockholders' equity to our target assets, our debt-to-equity ratio, and our economic debt-to-equity ratio as of September 30, 2024 and December 31, 2023. Our debt-to-equity ratio is calculated in accordance with U.S. GAAP and is the ratio of total debt to total stockholders' equity. As of September 30, 2024, approximately 94% of our equity is allocated to Agency RMBS.

We present an economic debt-to-equity ratio, a non-GAAP financial measure of leverage that considers the impact of the off-balance sheet financing of our investments in TBAs that are accounted for as derivative instruments under U.S. GAAP. We include our TBAs at implied cost basis in our measure of leverage because a forward contract to acquire Agency RMBS in the TBA market carries similar risks to Agency RMBS purchased in the cash market and funded with on-balance sheet liabilities. Similarly, a contract for the forward sale of Agency RMBS has substantially the same effect as selling the underlying Agency RMBS and reducing our on-balance sheet funding commitments. We believe that presenting our economic debt-to-equity ratio, when considered together with our U.S. GAAP financial measure of debt-to-equity ratio, provides information that is useful to investors in understanding how management evaluates our at-risk leverage and gives investors a comparable statistic to those of other mortgage REITs who also invest in TBAs and present a similar non-GAAP measure of leverage.

As of September 30, 2024

$ in thousands			Agency RMBS			Agency CMBS			Credit Portfolio (1)			Total
Mortgage-backed securities			5,181,013			675,074			17,609			5,873,696
Cash and cash equivalents (2)			42,190			6,064			—			48,254
Restricted cash (3)			115,416			4,783			—			120,199
Derivative assets, at fair value (3)			11,556			479			—			12,035
Other assets			25,598			2,448			—			28,046
Total assets			5,375,773			688,848			17,609			6,082,230
Repurchase agreements			4,535,956			648,929			—			5,184,885
Other liabilities			37,289			2,360			693			40,342
Total liabilities			4,573,245			651,289			693			5,225,227
Total stockholders' equity (allocated)			802,528			37,559			16,916			857,003
Debt-to-equity ratio (4)			5.7			17.3			—			6.1
Economic debt-to-equity ratio (5)			5.7			17.3			—			6.1

(1)Investments in non-Agency CMBS and non-Agency RMBS are included in credit portfolio.

(2)Cash and cash equivalents is allocated based on our financing strategy for each asset class.

(3)Restricted cash and derivative assets are allocated based on our hedging strategy for each asset class.

(4)Debt-to-equity ratio is calculated as the ratio of total repurchase agreements to total stockholders' equity.

(5)Economic debt-to-equity ratio is calculated as the ratio of total repurchase agreements and TBAs at implied cost basis to total stockholders' equity. We did not have any TBAs outstanding as of September 30, 2024.

45

---

Table of Contents

As of December 31, 2023

$ in thousands			Agency RMBS			Credit Portfolio (1)			Total
Mortgage-backed securities			5,027,232			18,074			5,045,306
U.S. Treasury securities			11,214			—			11,214
Cash and cash equivalents (2)			76,967			—			76,967
Restricted cash (3)			121,670			—			121,670
Derivative assets, at fair value (3)			939			—			939
Other assets			27,480			633			28,113
Total assets			5,265,502			18,707			5,284,209
Repurchase agreements			4,458,695			—			4,458,695
Other liabilities			42,117			732			42,849
Total liabilities			4,500,812			732			4,501,544
Total stockholders' equity (allocated)			764,690			17,975			782,665
Debt-to-equity ratio (4)			5.8			—			5.7
Economic debt-to-equity ratio (5)			5.8			—			5.7

(1)Investments in non-Agency CMBS, non-Agency RMBS and an unconsolidated joint venture are included in credit portfolio.

(2)Cash and cash equivalents is allocated based on our financing strategy for each asset class.

(3)Restricted cash and derivative assets are allocated based on our hedging strategy for each asset class.

(4)Debt-to-equity ratio is calculated as the ratio of total repurchase agreements to total stockholders' equity.

(5)Economic debt-to-equity ratio is calculated as the ratio of total repurchase agreements and TBAs at implied cost basis to total stockholders' equity. We did not have any TBAs outstanding as of December 31, 2023.

Liquidity and Capital Resources

Liquidity is a measure of our ability to meet potential cash requirements, including ongoing commitments to pay dividends, fund investments, repay borrowings and fund other general business needs. Our primary sources of funds for liquidity consist of the net proceeds from our common and preferred equity offerings, net cash provided by operating activities, proceeds from repurchase agreements and other financing arrangements and future issuances of equity and/or debt securities.

We currently believe that we have sufficient liquidity and capital resources available for the acquisition of additional investments, repayments on borrowings, margin requirements and the payment of cash dividends as required for continued qualification as a REIT. We generally maintain liquidity to pay down borrowings under repurchase arrangements to reduce borrowing costs and otherwise efficiently manage our long-term investment capital. Because the level of these borrowings can be adjusted on a daily basis, the level of cash and cash equivalents carried on our condensed consolidated balance sheets is significantly less important than our potential liquidity available under borrowing arrangements or through the sale of liquid investments. However, there can be no assurance that we will maintain sufficient levels of liquidity to meet any margin calls.

We held cash, cash equivalents and restricted cash of $168.5 million as of September 30, 2024 (September 30, 2023: $359.7 million). Our cash, cash equivalents and restricted cash change due to normal fluctuations in cash balances related to the timing of principal and interest payments, repayments of debt, and asset purchases and sales. Our operating activities provided net cash of approximately $121.3 million for the nine months ended September 30, 2024 (September 30, 2023: $206.1 million).

Our investing activities used net cash of $898.8 million in the nine months ended September 30, 2024 compared to net cash used by investing activities of $899.8 million in the nine months ended September 30, 2023. Our primary source of cash from investing activities for the nine months ended September 30, 2024 was proceeds from sales of MBS of $887.2 million and proceeds from sales of U.S. Treasury securities of $10.8 million (September 30, 2023: $3.3 billion from the sales of MBS). We also generated $261.9 million from principal payments of MBS during the nine months ended September 30, 2024 (September 30, 2023: $260.9 million) and used cash of $146.5 million to settle derivative contracts in the nine months ended September 30, 2024 (September 30, 2023: net cash provided of $19.6 million). We used cash of $1.9 billion to purchase MBS during the nine months ended September 30, 2024 (September 30, 2023: $4.5 billion to purchase MBS).

Our financing activities provided net cash of $747.3 million for the nine months ended September 30, 2024 compared to net cash provided by financing activities of $774.6 million in the nine months ended September 30, 2023. During the nine months ended September 30, 2024, we received net cash from proceeds on our repurchase agreements of $726.6 million

46

---

Table of Contents

(September 30, 2023: $752.2 million). We used cash of $75.7 million for the nine months ended September 30, 2024 to pay dividends (September 30, 2023: $77.1 million). Proceeds from issuance of common stock provided $108.1 million for the nine months ended September 30, 2024 (September 30, 2023: $109.1 million).

As of September 30, 2024, the average margin requirement (weighted by borrowing amount), or the haircut, under our repurchase agreements was 4.3% for Agency RMBS and 4.5% for Agency CMBS. The haircuts ranged from a low of 3% to a high of 5% for Agency RMBS and a low of 3% to a high of 5% for Agency CMBS. Declines in the value of our securities portfolio can trigger margin calls by our lenders under our repurchase agreements. An event of default or termination event may give our counterparties the option to terminate all repurchase transactions outstanding with us and require any amount due from us to the counterparties to be payable immediately.

Effects of Margin Requirements, Leverage and Credit Spreads

Our securities have values that fluctuate according to market conditions and the market value of our securities will decrease as prevailing interest rates or credit spreads increase. When the value of the securities pledged to secure a repurchase loan decreases to the point where the positive difference between the collateral value and the loan amount is less than the haircut, our lenders may issue a “margin call”, which means that the lender will require us to pay cash or pledge additional collateral. Under our repurchase facilities, our lenders have full discretion to determine the value of the securities we pledge to them. Most of our lenders will value securities based on recent trades in the market. Lenders also issue margin calls as the published current principal balance factors change on the pool of mortgages underlying the securities pledged as collateral when scheduled and unscheduled paydowns are announced monthly.

We experience margin calls and increased collateral requirements in the ordinary course of our business. In seeking to effectively manage the margin requirements established by our lenders, we maintain a position of cash and unpledged securities. We refer to this position as our liquidity. The level of liquidity we have available to meet margin calls is directly affected by our leverage levels, our haircuts and the price changes on our securities. If interest rates increase as a result of a yield curve shift or for another reason or if credit spreads widen, then the prices of our collateral (and our unpledged assets that constitute our liquidity) will decline, we will experience margin calls, and we will seek to use our liquidity to meet the margin calls. There can be no assurance that we will maintain sufficient levels of liquidity to meet any margin calls or increased collateral requirements. If our haircuts increase, our liquidity will proportionately decrease. In addition, if we increase our borrowings, our liquidity will decrease by the amount of additional haircut on the increased level of indebtedness.

We intend to maintain a level of liquidity in relation to our assets that enables us to meet reasonably anticipated margin calls and increased collateral requirements but that also allows us to be substantially invested in securities. We may misjudge the appropriate amount of our liquidity by maintaining excessive liquidity, which would lower our investment returns, or by maintaining insufficient liquidity, which would force us to liquidate assets into unfavorable market conditions and harm our results of operations and financial condition.

We are subject to financial covenants in connection with our lending, derivatives and other agreements we enter into in the normal course of our business. We intend to operate in a manner which complies with all of our financial covenants. Our lending and derivative agreements provide that we may be declared in default of our obligations if our leverage ratio exceeds certain thresholds and we fail to maintain stockholders’ equity or market value above certain thresholds over specified time periods.

Forward-Looking Statements Regarding Liquidity

As of September 30, 2024, we held $5.4 billion of Agency securities that are financed by repurchase agreements. We also had approximately $472.3 million of unencumbered investments and unrestricted cash of $48.3 million as of September 30, 2024. As of September 30, 2024, our known contractual obligations primarily consisted of $5.2 billion of repurchase agreement borrowings with a weighted average remaining maturity of 32 days. We generally intend to refinance the majority of our repurchase agreement borrowings at market rates upon maturity. Repurchase agreement borrowings that are not refinanced upon maturity are typically repaid through the use of cash on hand or proceeds from sales of securities.

Based upon our current portfolio and existing borrowing arrangements, we believe that cash flow from operations and available borrowing capacity will be sufficient to enable us to meet anticipated short-term (one year or less) liquidity requirements to fund our investment activities, fund our announced redemption of Series B Preferred Stock, pay fees under our management agreement, fund our required distributions to stockholders and fund other general corporate expenses.

Our ability to meet our long-term (greater than one year) liquidity and capital resource requirements will be subject to obtaining additional debt financing. We may increase our capital resources by obtaining long-term credit facilities or through public or private offerings of equity or debt securities, possibly including classes of preferred stock, common stock, senior or subordinated notes and convertible notes. Such financing will depend on market conditions for capital raises and our ability to

47

---

Table of Contents

invest such offering proceeds. If we are unable to renew, replace or expand our sources of financing on substantially similar terms, it may have an adverse effect on our business and results of operations.

Exposure to Financial Counterparties

We finance a substantial portion of our investment portfolio through repurchase agreements. Under these agreements, we pledge assets from our investment portfolio as collateral. Additionally, certain counterparties may require us to provide cash collateral in the event the market value of the assets declines to maintain a contractual repurchase agreement collateral ratio. If a counterparty were to default on its obligations, we would be exposed to potential losses to the extent the fair value of collateral pledged by us to the counterparty including any accrued interest receivable on such collateral exceeded the amount loaned to us by the counterparty plus interest due to the counterparty.

As of September 30, 2024, no counterparty held collateral that exceeded the amounts borrowed under the related repurchase agreements by more than $42.9 million, or 5% of our stockholders' equity. The following table summarizes our exposure to counterparties by geographic concentration as of September 30, 2024. The information is based on the geographic headquarters of the counterparty or counterparty's parent company. However, our repurchase agreements are denominated in U.S. dollars.

$ in thousands			Number of Counterparties						Repurchase Agreement Financing						Exposure
North America			13						3,192,088						(142,441)
Europe (excluding United Kingdom)			2						675,444						(27,727)
Asia			4						858,367						(38,769)
United Kingdom			1						458,986						(17,858)
Total			20						5,184,885						(226,795)

Dividends

To maintain our qualification as a REIT, U.S. federal income tax law generally requires that we distribute at least 90% of our REIT taxable income annually, determined without regard to the deduction for dividends paid and excluding net capital gains. We must pay tax at regular corporate rates to the extent that we annually distribute less than 100% of our REIT taxable income. Before we pay any dividend, whether for U.S. federal income tax purposes or otherwise, we must first meet both our operating requirements and debt service on our repurchase agreements and other debt payable. If our cash available for distribution is less than our REIT taxable income, we could be required to sell assets or borrow funds to make cash distributions, or we may make a portion of the required distribution in the form of a taxable stock distribution or distribution of debt securities.

As discussed above, our distribution requirements are based on REIT taxable income rather than U.S. GAAP net income. The primary differences between our REIT taxable income and U.S. GAAP net income are: (i) unrealized gains and losses on investments that we have elected the fair value option for that are included in current U.S. GAAP income but are excluded from REIT taxable income until realized or settled; (ii) gains and losses on derivative instruments that are included in current U.S. GAAP net income but are excluded from REIT taxable income until realized; and (iii) temporary differences related to amortization of premiums and discounts on investments. For additional information regarding the characteristics of our dividends, refer to Note 12 – "Stockholders' Equity" of our annual report on Form 10-K for the year ended December 31, 2023.

Unrelated Business Taxable Income

We have not engaged in transactions that would result in a portion of our income being treated as unrelated business taxable income.

Other Matters

We believe that we satisfied each of the asset tests in Section 856(c)(4) of the Internal Revenue Code of 1986, as amended (the "Code") for the period ended September 30, 2024, and that our proposed method of operation will permit us to satisfy the asset tests, gross income tests, and distribution and stock ownership requirements for our taxable year that will end on December 31, 2024.

At all times, we intend to conduct our business so that neither we nor our Operating Partnership nor the subsidiaries of our Operating Partnership are required to register as an investment company under the 1940 Act. If we were required to register as an investment company, then our use of leverage would be substantially reduced. Because we are a holding company that

48

---

Table of Contents

conducts our business through our Operating Partnership and the Operating Partnership’s wholly-owned or majority-owned subsidiaries, the securities issued by these subsidiaries that are excepted from the definition of "investment company" under Section 3(c)(1) or Section 3(c)(7) of the 1940 Act, together with any other investment securities the Operating Partnership may own, may not have a combined value in excess of 40% of the value of the Operating Partnership’s total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis, which we refer to as the 40% test. This requirement limits the types of businesses in which we are permitted to engage in through our subsidiaries. In addition, we believe neither we nor the Operating Partnership are considered an investment company under Section 3(a)(1)(A) of the 1940 Act because they do not engage primarily or hold themselves out as being engaged primarily in the business of investing, reinvesting or trading in securities. Rather, through the Operating Partnership’s wholly-owned or majority-owned subsidiaries, we and the Operating Partnership are primarily engaged in the non-investment company businesses of these subsidiaries. IAS Asset I LLC and certain of the Operating Partnership’s other subsidiaries that we may form in the future rely upon the exclusion from the definition of "investment company" under the 1940 Act provided by Section 3(c)(5)(C) of the 1940 Act, which is available for entities "primarily engaged in the business of purchasing or otherwise acquiring mortgages and other liens on and interests in real estate." This exclusion generally requires that at least 55% of each subsidiary’s portfolio be comprised of qualifying assets and at least 80% be comprised of qualifying assets and real estate-related assets (and no more than 20% comprised of miscellaneous assets). We calculate that as of September 30, 2024, we conducted our business so as not to be regulated as an investment company under the 1940 Act.

ITEM 3.     QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

The primary components of our market risk are related to interest rate, principal prepayment and market value. While we do not seek to avoid risk completely, we believe the risk can be quantified from historical experience and we seek to actively manage that risk, to earn sufficient compensation to justify taking those risks and to maintain capital levels consistent with the risks we undertake.

For additional discussion of market risk, see Part I. Item 1 - Risk Factors of our annual report on Form 10-K for the year ended December 31, 2023.

Interest Rate Risk

Interest rate risk is highly sensitive to many factors, including governmental, monetary and tax policies, domestic and international economic and political considerations, and other factors beyond our control. We are subject to interest rate risk in connection with our investments and our repurchase agreements. Our repurchase agreements are typically short-term in nature and are periodically refinanced at current market rates. We typically mitigate this interest rate risk by utilizing derivative contracts, primarily interest rate swap agreements and futures contracts.

Interest Rate Effect on Net Interest Income

Our operating results depend in large part upon differences between the yields earned on our investments and our cost of borrowing and interest rate hedging activities. During periods of rising interest rates, the borrowing costs associated with our investments tend to increase while the income earned on our fixed interest rate investments may remain substantially unchanged. This increase in borrowing costs results in the narrowing of the net interest spread between the related assets and borrowings and may even result in losses. Further, defaults could increase and result in credit losses to us, which could adversely affect our liquidity and operating results. Such delinquencies or defaults could also have an adverse effect on the spread between interest-earning assets and interest-bearing liabilities.

Hedging techniques are partly based on assumed levels of prepayments of our RMBS. If prepayments are slower or faster than assumed, the life of the RMBS will be longer or shorter, which would reduce the effectiveness of any hedging strategies we may use and may cause losses on such transactions. Hedging strategies involving the use of derivative securities are highly complex and may produce volatile returns.

Interest Rate Effects on Fair Value

Another component of interest rate risk is the effect that changes in interest rates will have on the market value of the assets that we acquire. We face the risk that the market value of our assets will increase or decrease at different rates than those of our liabilities, including our hedging instruments.

We primarily assess our interest rate risk by estimating the duration of our assets and the duration of our liabilities. Duration measures the market price volatility of financial instruments as interest rates change. We generally calculate duration using various financial models and empirical data. Different models and methodologies can produce different duration values for the same securities.

The impact of changing interest rates on fair value can change significantly when interest rates change materially. Therefore, the volatility in the fair value of our assets could increase significantly in the event interest rates change materially.

49

---

Table of Contents

In addition, other factors impact the fair value of our interest rate-sensitive investments and hedging instruments, such as the shape of the yield curve, market expectations as to future interest rate changes and other market conditions. Accordingly, changes in actual interest rates may have a material adverse effect on us.

Spread Risk

We refer to the difference between interest rates on our investments and interest rates on risk free instruments as spreads. We employ a variety of spread risk management techniques that seek to mitigate the influences of spread changes on our book value and our liquidity to help us achieve our investment objectives. The yield on our investments changes over time due to the level of risk free interest rates, the creditworthiness of the security, and the price of the perceived risk. The change in the market yield of our interest rate hedges also changes primarily with the level of risk free interest rates. We manage spread risk through careful asset selection, sector allocation, regulating our portfolio value-at-risk, and seeking to maintain adequate liquidity. Changes in spreads impact our book value and our liquidity and could cause us to sell assets and to change our investment strategy to maintain liquidity and preserve book value.

Inflation, financial conditions, monetary policy initiatives, interest rates and interest rate volatility may have an impact on credit spreads.

Prepayment Risk

As we receive prepayments of principal on our investments, premiums or discounts on these investments are amortized against interest income. In general, an increase in prepayment rates will accelerate the amortization of purchase premiums, thereby reducing the interest income earned on the investments. Conversely, discounts on such investments are accreted into interest income. In general, an increase in prepayment rates will accelerate the accretion of purchase discounts, thereby increasing the interest income earned on the investments.

Uncertainty regarding the rate of inflation, fiscal and monetary policy initiatives, elevated interest rate volatility and other factors have made it more difficult to predict prepayment levels for the securities in our portfolio. As a result, it is possible that realized prepayment behavior will be materially different from our expectations.

Extension Risk

We compute the projected weighted average life of our investments based upon assumptions regarding the rate at which the borrowers will prepay the underlying mortgages. In general, when a fixed-rate or hybrid adjustable-rate security is acquired with borrowings, we may, but are not required to, enter into an interest rate swap agreement or other hedging instrument that effectively fixes our borrowing costs for a period close to the anticipated average life of the fixed-rate portion of the related assets. This strategy is designed to protect us from rising interest rates, because the borrowing costs are fixed for the duration of the fixed-rate portion of the related target asset.

However, if prepayment rates decrease in a rising interest rate environment, then the life of the fixed-rate portion of the related assets could extend beyond the term of the swap agreement or other hedging instrument. This could have a negative impact on our results from operations, as borrowing costs would no longer be fixed after the end of the hedging instrument, while the income earned on the hybrid adjustable-rate assets would remain fixed. This situation may also cause the market value of our hybrid adjustable-rate assets to decline, with little or no offsetting gain from the related hedging transactions. In extreme situations, we may be forced to sell assets to maintain adequate liquidity, which could cause us to incur losses.

Market Risk

Market Value Risk

Our available-for-sale securities are reflected at their estimated fair value with unrealized gains and losses excluded from earnings and reported in other comprehensive income under ASC Topic 320. The estimated fair value of these securities fluctuates primarily due to changes in interest rates and other factors. Generally, in a rising interest rate environment, the estimated fair value of these securities would be expected to decrease; conversely, in a falling interest rate environment, the estimated fair value of these securities would be expected to increase.

Pandemics and other widespread crises, including any related fiscal or monetary policy responses, may cause extreme volatility and illiquidity in fixed income markets. The amount of financing we receive under our repurchase agreements is directly related to our counterparties’ valuation of our assets that collateralize the outstanding repurchase agreement financing. When these or similar market conditions are present, margin call risk is elevated and our operating results and financial condition may be materially impacted.

The sensitivity analysis table presented below shows the estimated impact of an instantaneous parallel shift in the yield curve, up and down 50 and 100 basis points, on the market value of our interest rate-sensitive investments and net interest income, including net interest paid or received under interest rate swaps, as of September 30, 2024 and December 31, 2023, assuming a static portfolio and constant financing and credit spreads. When evaluating the impact of changes in interest rates,

50

---

Table of Contents

prepayment assumptions and principal reinvestment rates are adjusted based on our Manager’s expectations. The analysis presented utilized assumptions, models and estimates of our Manager based on our Manager’s judgment and experience.

						As of September 30, 2024												As of December 31, 2023
Change in Interest Rates						Percentage Change in Projected Net Interest Income						Percentage Change in Projected Portfolio Value						Percentage Change in Projected Net Interest Income						Percentage Change in Projected Portfolio Value
+1.00%						(2.68)		%				(0.93)		%				(1.04)		%				(0.76)		%
+0.50%						(1.11)		%				(0.30)		%				(0.41)		%				(0.23)		%
-0.50%						0.91		%				(0.08)		%				0.27		%				(0.13)		%
-1.00%						2.08		%				(0.59)		%				0.93		%				(0.68)		%

Certain assumptions have been made in connection with the calculation of the information set forth in the foregoing interest rate sensitivity table and, as such, there can be no assurance that assumed events will occur or that other events will not occur that would affect the outcomes. The interest rate scenarios assume interest rates as of September 30, 2024 and December 31, 2023. Furthermore, while the analysis reflects the estimated impact of interest rate increases and decreases on a static portfolio, we actively manage the size and composition of our investment and swap portfolios, which can result in material changes to our interest rate risk profile. When applicable, our scenario analysis assumes a floor of 0% for U.S. Treasury yields and, to be consistent, we also apply a floor of 0% for all related funding costs.

The information set forth in the interest rate sensitivity table above and all related disclosures constitutes forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Actual results could differ significantly from those estimated in the foregoing interest rate sensitivity table.

Real Estate Risk

Residential and commercial property values are subject to volatility and may be adversely affected by a number of factors, including, but not limited to: national, regional and local economic conditions (which may be adversely affected by industry slowdowns and other factors); local real estate conditions (such as the supply of housing stock or other property sectors); changes or continued weakness in specific industry segments; construction quality, age and design; demographic factors; and retroactive changes to building or similar codes. In addition, decreases in property values reduce the value of the collateral and the potential proceeds available to a borrower to repay our loans, which could also cause us to suffer losses.

Credit Risk

We retain the risk of potential credit losses on all of our residential and commercial mortgage investments. We seek to manage this risk through our pre-acquisition due diligence process. In addition, we re-evaluate the credit risk inherent in our investments on a regular basis pursuant to fundamental considerations such as GDP, unemployment, interest rates, retail sales, store closings/openings, corporate earnings, housing inventory, affordability and regional home price trends. We also review key loan credit metrics including, but not limited to, payment status, current loan-to-value ratios, current borrower credit scores and debt yields. These characteristics assist in determining the likelihood and severity of loan loss as well as prepayment and extension expectations. We then perform structural analysis under multiple scenarios to establish likely cash flow profiles and credit enhancement levels relative to collateral performance projections. This analysis allows us to quantify our opinions of credit quality and fundamental value, which are key drivers of portfolio management decisions.

Deteriorating fundamentals and tightening lending conditions may cause borrowers to experience difficulties meeting their obligations and refinancing loans upon scheduled maturities. Loans may experience increasing delinquency levels and eventual defaults, which could impact the performance of our mortgage-backed securities. Rating agencies periodically reassess transactions negatively impacted by these adverse changes, which may result in our investments being downgraded.

Risk Management

To the extent consistent with maintaining our REIT qualification, we seek to manage risk exposure to protect our investment portfolio against the effects of major interest rate changes. We generally seek to manage this risk by:

•monitoring and adjusting, if necessary, the reset index and interest rate related to our target assets and our financings;

•attempting to structure our financing agreements to have a range of different maturities, terms, amortizations and interest rate adjustment periods;

•exploring options to obtain financing arrangements that are not marked to market;

•using hedging instruments, primarily interest rate swap agreements but also financial futures, options, interest rate cap agreements, floors and forward sales to adjust the interest rate sensitivity of our target assets and our borrowings; and

51

---

Table of Contents

•actively managing, on an aggregate basis, the interest rate indices, interest rate adjustment periods, and gross reset margins of our target assets and the interest rate indices and adjustment periods of our financings.

ITEM 4.     CONTROLS AND PROCEDURES.

Our management is responsible for establishing and maintaining disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act.

We have evaluated, with the participation of our principal executive officer and principal financial officer, the effectiveness of our disclosure controls and procedures as of September 30, 2024. Based upon our evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the applicable rules and forms, and that it is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.

Changes in Internal Control over Financial Reporting    

There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the quarter ended September 30, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

52

---

Table of Contents

PART II – OTHER INFORMATION

 

ITEM 1.     LEGAL PROCEEDINGS.

From time to time, we may be involved in various claims and legal actions arising in the ordinary course of business. As of September 30, 2024, we were not involved in any such legal proceedings.

ITEM 1A.     RISK FACTORS.

There were no material changes during the period covered by this Quarterly Report to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on February 22, 2024. Additional risks not presently known, or that we currently deem immaterial, also may have a material adverse effect on our business, financial condition and results of operations.

ITEM 2.     UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

The following tables sets forth information with respect to our repurchases of Series C Preferred Stock during the three months ended September 30, 2024.

Month			Total Number of Shares Purchased			Average Price Paid Per Share			Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)			Maximum Number at end of period of Shares that May Yet Be Purchased Under the Plans or Programs (1)
July 1, 2024 to July 31, 2024			23,245			22.94			23,245			820,785
August 1, 2024 to August 31, 2024			28,615			24.04			28,615			792,170
September 1, 2024 to September 30, 2024			14,647			24.64			14,647			777,523
			66,507			23.80			66,507

(1)In May 2022, our board of directors approved a share repurchase program under which we may purchase up to 3,000,000 shares of our Series B Preferred Stock and 5,000,000 shares of our Series C Preferred Stock with no stated expiration date. The shares may be repurchased from time to time through privately negotiated transactions or open market transactions, including under a trading plan in accordance with Rules 10b5-1 and 10b-18 under Exchange Act or by any combination of such methods. The manner, price, number and timing of share repurchases are subject to a variety of factors, including market conditions and applicable SEC rules.

ITEM 3.     DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4.     MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5.     OTHER INFORMATION.

None.

ITEM 6.     EXHIBITS.

A list of exhibits to this Form 10-Q is set forth on the Exhibit Index and is incorporated herein by reference.

53

---

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

			INVESCO MORTGAGE CAPITAL INC.
November 5, 2024			By:			/s/ John M. Anzalone
						John M. Anzalone
						Chief Executive Officer
November 5, 2024			By:			/s/ Mark Gregson
						Mark Gregson
						Interim Chief Financial Officer

54

---

Table of Contents

EXHIBIT INDEX

Item 6.        Exhibits

 

Exhibit No.						Description
3.1						Articles of Amendment and Restatement of Invesco Mortgage Capital Inc. (incorporated by reference to Exhibit 3.1 to our Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission ("SEC") on August 12, 2009).
3.2						Articles Supplementary of 7.75% Fixed-to-Floating Series B Cumulative Redeemable Preferred Stock (incorporated by reference to Exhibit 3.3 to the Registrant’s Registration Statement on Form 8-A, filed with the SEC on September 8, 2014).
3.3						Articles Supplementary classifying 1,500,000 shares of the Company’s preferred stock as additional Series B Shares (incorporated by reference to Exhibit 3.2 to the Current Report on Form 8-K, filed with the SEC on March 19, 2019).
3.4						Articles Supplementary of 7.50% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock (incorporated by reference to Exhibit 3.4 to the Registrant’s Registration Statement on Form 8-A, filed with the SEC on August 11, 2017).
3.5						Articles Supplementary classifying 4,000,000 shares of the Company’s preferred stock as additional Series C Shares (incorporated by reference to Exhibit 3.3 to the Current Report on Form 8-K, filed with the SEC on March 19, 2019).
3.6						Articles Supplementary reclassifying 2,110,000 shares of authorized but unissued shares of Series A Preferred Stock as shares of Preferred Stock without designation (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on June 17, 2021).
3.7						Articles of Amendment of Invesco Mortgage Capital Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on June 3, 2022).
3.8						Articles of Amendment of Invesco Mortgage Capital Inc. (incorporated by reference to Exhibit 3.2 to the Current Report on Form 8-K, filed with the SEC on June 3, 2022).
3.9						Articles of Amendment (Authorized shares) (incorporated by reference to Exhibit 3.9 to the Quarterly Report on Form 10-Q, filed with the SEC on August 4, 2022).
3.10						Articles of Amendment (Authorized shares) (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on August 9, 2024).
3.11						Amended and Restated Bylaws of Invesco Mortgage Capital Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on February 17, 2017).
10.1						Equity Distribution Agreement, dated August 9, 2024, among the Company, the Operating Partnership, its Manager and the Placement Agents (incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K, filed with the SEC on August 9, 2024).
31.1						Certification of John M. Anzalone pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2						Certification of Mark Gregson pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*						Certification of John M. Anzalone pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*						Certification of Mark Gregson pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101						101.INS XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.   101.SCH XBRL Taxonomy Extension Schema Document   101.CAL XBRL Taxonomy Calculation Linkbase Document   101.LAB XBRL Taxonomy Label Linkbase Document   101.PRE XBRL Taxonomy Presentation Linkbase Document   101.DEF XBRL Taxonomy Definition Linkbase Document
104						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*Furnished herewith

55